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Bacteriophages previously found in the feedlot environment may play a role in the 
ecology of Salmonella in the feedlot environment and also prove useful as a means of controlling 
this pathogen in beef. The ability of a phage to infect and lyse the target bacterial strain is 
generally agreed to be a basic requirement for successful phage therapy. The objective of this 
work was to 1) determine phage host range and virulence in a microtiter-plate based liquid assay 
using the features of an automated plate reader to monitor culture optical density over time in an 
incubating, aerated environment; 2) perform phage characterizations, including morphological 
identification, growth kinetics, genomic analysis and 3) conduct antimicrobial efficacy testing of 
phages in ex-vivo models and study relationship between phage efficiency in bacterial reduction 
and phage characterization.  
Host range scores obtained by two methods were compared to each other and to results 
from a study using phages to decontaminate cattle hides inoculated with S. Anatum, in order to 
determine the ability of the two host range methods to predict antimicrobial efficacy of phages in 
an ex vivo model. The host ranges of the tested phages were highly variable, ranging from 
infecting 10% to 85% of the tested Salmonella strains.  Phage Melville was found to have the 
broadest host range, capable of infecting 85% (17/20) in both methods. Results obtained by the 
microtiter plate liquid method were found to have higher discriminatory power between bacterial 
strains. The ability of phages to reduce Salmonella loads on cattle hides were correlated with the 
results obtained by the microtiter plate method developed in this study but not with the 






of antimicrobial capacity of phages compared to traditional agar overlay methods. The microtiter 
plate liquid assay could potentially serve as a more advanced alternative of characterizing phages 
that yields data on both host range and virulence. Bacteriophage capable of significantly reduce 
Salmonella population in cattle hide and soil proved the possible function as an intervention 
against Salmonella to prevent pathogen transmission in feedlot environment and colonization of 
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CHAPTER I  
INTRODUCTION AND LITERATURE REVIEW 
 
Salmonella and Salmonellosis 
Bacteria of the genus Salmonella are facultatively anaerobic, Gram-negative, non spore-
forming rod-shaped enteric bacteria belonging to the family Enterobacteriaceae [1]. Although 
Salmonella spp. are generally motile with peritrichous flagella, non-flagellated and non-motile 
strains with dysfunctional flagella do exist [2]. Salmonella are able to utilize a wide range of 
organic compounds and metabolize nutrients via respiratory and fermentative pathways [2]. 
Isolates generally catabolize glucose with production of acid and gas. Most strains are unable to 
ferment lactose, though several mutants that have ability to utilize lactose have been identified 
[3]. Salmonella are oxidase negative, catalase positive, indole negative, Voges-Proskauer 
negative, methyl red positive, and are able to grow on citrate as a sole carbon source [1]. They 
produce hydrogen sulfide, decarboxylate lysine and ornithine, and do not produce urease [2].  
The genus Salmonella is divided into two species: S. enterica and S. bongori, with S. 
enterica divided into six subspecies (enterica, salamae, arizonae, diarizonae, houtenae, and 
indica) [4]. The majority of human Salmonella infections are caused by S. enterica subsp. 
enterica [1]. Subspecies are divided into more than 2,600 serotypes based on their serological 
reaction to somatic lipopolysaccharide (O), flagellar (H) and capsular antigens according to the 
Kauffmann-White Scheme [4]. Ninety-nine percent of serotypes were found within the species S. 






Salmonella serotyping is maintained by World Health Organization (WHO) Collaborating Center 
for Reference and Research on Salmonella at Institut Pasteur, Paris, France [5].   
Salmonella are mesophilic and can grow within a temperature range of 5.2 to 46.2 °C, 
with the optimal temperatures for growth from 35 to 43 °C [6]. Many factors may enhance heat 
resistance of Salmonella: low water activity, high fatty acid content, and sub-lethal stimulation 
could increase the heat resistance of this organism [2]. Freezing can be detrimental to 
Salmonella, but it does not guarantee destruction [2]. A 0.2 log10 CFU/ml reduction of S. 
Typhimurium was observed on chicken carcasses during crust freezing [7]. However, Salmonella 
are able to survive longer under frozen conditions compared to ambient and refrigeration 
temperature [6]. The optimal water activity (aw) for the growth of Salmonella is 0.99 and the 
minimal aw limit is 0.93. Salmonella are capable to survive for months in foods with low aw such 
as nuts and spices [6]. Salmonella can grow in a broad pH range from 3.8 to 9.5, with an 
optimum pH range for growth of 7.0 to 7.5. However, the capacity for growth in extreme pH 
condition is dependent on other factors such as the presence of chemicals, temperature and aw 
[2]. 
Salmonellosis is a human gastrointestinal (GI) illness caused by exposure to non-
typhoidal Salmonella spp. Outcomes of non-typhoidal Salmonella infection can range from 
asymptomatic colonization of the GI tract to acute gastroenteritis, septicemia, bacteremia or 
chronic conditions such as arthritis [8]. The pathogenesis of Salmonella is complex and the 
severity displayed during infections in human is variable depending on genotype involved and 
health status of individuals [1,9]. After the organism is ingested via a cross-contaminated food, 






producing a heat-stable enterotoxin that causes an inflammatory reaction [1]. The inflammatory 
reaction causes symptoms typical of gastroenteritis including watery diarrhea, persistent and 
spiking fever, abdominal pain, headache, nausea, prostration, and a rash of rose-colored spots on 
the shoulders, thorax, or abdomen [10]. Salmonella could also achieve internalization via type III 
secretion system [10]. Approximately 5% of individuals with gastroenteritis caused by non-
typhoidal Salmonella infection develop bacteremia, which occurs when Salmonella spp. enter the 
bloodstream [8]. Bacteremia is associated with fever greater than 39 oC, lethargy, abdominal and 
chest pain, chills and anorexia [1]. Reactive arthritis, a chronic sequelum, may occur after 
Salmonella infection and is estimated to happen in 12 cases per 1,000 Salmonella infections [11]. 
The incubation period for typical Salmonella infection is 6 to 72 hours and illness generally lasts 
2 to 7 days [1,8]. The infectious dose was reported large (105 – 1010) in volunteer study, but data 
from outbreaks indicated that the infectious dose could be as low as a few cells [1,12]. Factors 
that affect the determination of infectious dose include immunological heterogeneity within 
human populations, virulence of infecting strains and chemical composition of contaminated 
food [2]. Infants, the elderly, and immunocompromised individuals are more susceptible to 
Salmonella infections than adults [2]. Foods with high fat content are more likely to be 
associated with low-dose Salmonella infection. Organisms may be protected against the 
bactericidal action of gastric acidity by being encapsulated within hydrophobic lipid micelles [2].  
 
Epidemiological and Economic Impacts of Salmonella 
Salmonella is a leading cause of bacterial foodborne illness in the United States. 






the United States, with more than 23,000 hospitalizations and 450 deaths [13]. During 2017, 
24,484 foodborne infections were identified by culture-confirmed or culture-independent 
diagnostic tests (CIDs) via the FoodNet network [14]. The second most common cause of 
foodborne bacterial illness identified by both culture or CIDs, Salmonella accounted for 8,172 
infections (34% of total foodborne infections), 2,255 hospitalizations (28% of Salmonella 
infections) and 40 deaths (0.5% of Salmonella infections) were identified through FoodNet 
during 2016 [15]. The incidence of salmonellosis increased from 14.51 per 100,000 population in 
2016 to 16 in 2017, and it has remained stable with minor fluctuation over the long term from 
2000 (Figure 1) [13,14,16-18] .  
During 2009 to 2015, Salmonella was the leading cause of bacterial foodborne illness 
outbreaks in the United States, with 896 outbreaks (30%) out of 2,442 outbreaks identified. 
Outbreaks caused by Salmonella  resulted in 23,663 illnesses, 3,168 hospitalizations (65% of 
total hospitalizations associated with outbreaks) and 29 deaths [19]. Among the top 5 pathogen-
food category pairs resulting in outbreak-associated illness, Salmonella was associated with 4 
pairs, including eggs, seeded vegetables, chicken and pork [19]. In addition, Salmonella caused 
the largest multistate foodborne illness outbreak among 177 cases reported, in which 1,939 
persons were infected in 10 states beginning in 2010 [19,20].  
Figure 2 from the United States Department of Agriculture (USDA) Economic Research 
Service (ERS) indicates that Salmonella imposes the greatest cost of 14 major foodborne 
pathogens investigated in the United States [21,22]. In 2010, the estimated annual economic cost 







Figure 1. Incidence rate of Salmonella infections in the U.S. Incidence rate of laboratory-confirmed human non-typhoidal Salmonella 
































































































































Figure 2. Annual cost and percentage cost estimates in 2010 U.S. dollars based on disease incidence estimates published 2010. 






and included medical costs due to illness, the cost of time lost from work due to nonfatal illness, 
and the cost of premature deaths [21]. 
 
Antimicrobial Resistance of Salmonella 
In the United States, severe non-typhoidal salmonellosis is commonly treated with 
fluoroquinolone and third-generation cephalosporin antibiotics [23]. Recently recognized 
decreases in susceptibility to ceftriaxone indicates a possible pattern of increasing resistance to 
3rd generation cephalosporins [24]. Other antibiotics such as macrolides, penicillins and 
trimethoprim- sulfamethoxazole may be of clinical importance [23]. The Centers for Disease 
Control and Prevention (CDC; Atlanta, GA) National Antimicrobial Resistance Monitoring 
System (NARMS) reported 3% of tested clinical non-typhoidal Salmonella isolates were 
resistant to ceftriaxone and nalidixic acid [23] in 2012. Nine percent of non-typhoidal Salmonella 
isolates tested were resistant to three or more antibiotic classes [23]. Compared to NARMS-
reported data from 2003-2007, Salmonella isolates resistant to three or more antibiotic classes 
was lower in 2012 than in 2003–2007 (12% vs. 9%). However, the differences in resistance to 
nalidixic acid and ceftriaxone between 2003-2007 and 2012 are not significant (Figure 3, 4) [23]. 
Crump et al. [25] summarized antimicrobial resistance among invasive non-typhoidal 
Salmonella submitted to NARMS from 1996 to 2007 and found that 19.8% were resistant to 
ampicillin, 11.1% to chloramphenicol and 2.5% to trimethoprim-sulfamethoxazole; 2.7% isolates 
were resistant to nalidixic acid and 2.5% to ceftriaxone. Previous research has shown that 





















develop bloodstream infection (bacteremia) compared to patients with pan-susceptible 
Salmonella infection [26]. 
In the United States, there are 1.2 million estimated Salmonella annual infections, 
100,000 cases and 40 deaths estimated to be caused by drug-resistant Salmonella [27]. From 
1984 to 2002, among non-typhoidal Salmonella outbreaks in which antimicrobial resistance 
information is available, 28% of outbreaks were caused by antimicrobial-resistant strains [28]. 
Outbreaks caused by antimicrobial-resistant non-typhoidal Salmonella resulted in greater 
hospitalization rates and a greater portion of deaths [26,28]. 
Antibiotic-resistant bacteria can be spread from person to person, and from non-human 
sources in the environment such as food [27]. The over-prescription of antibiotics in food 
animals may contribute to the emergence of antibiotic-resistant bacteria, which is concerning 
because people can develop infections by consuming food contaminated with antibiotic-resistant 
bacteria from these animals, resulting in reduced efficacy of antimicrobials for disease therapy 
[27]. Therefore, antibiotics must be cautiously used in animal food production and antimicrobial 
substitutes have to be developed to prevent the emergence and spread of antibiotic-resistant 
bacteria.     
 
Salmonella Carriage in the Lymph Nodes of Beef Cattle  
In the U.S., commercial ground beef was reported in 2009 to be contaminated with 
Salmonella at a rate of 4.2% [29], despite the adoption of antimicrobial interventions on the 
carcass such as sodium hydroxide, sodium sulfide, chlorine, lactic acid and acetic acid solutions 






beef carcasses from 50.2% to 0.8%, but have little effect on ground beef made from edible beef 
trimmings [31]. The carriage of Salmonella in the lymph nodes of beef cattle may contribute to 
the transmission of the pathogen to consumers via ground beef. Gragg et al. [32] reported that 
Salmonella enterica was found in asymptomatic cattle lymph nodes at slaughter, which means in 
a low dose infection, beef cattle could serve as Salmonella carriers without being detected. 
Without showing any clinical symptoms of Salmonella infection or carriage, detection of beef 
cattle carrying Salmonella is difficult. Therefore, there risks of releasing Salmonella-
contaminated ground beef to consumers. 
Major lymph nodes are reported to have relatively high Salmonella prevalence in beef 
cattle. Mandibular, mesenteric, mediastinal, and sub-iliac nodes, which may be removed during 
evisceration, reportedly may harbor Salmonella at rates of 55.9% (95% CL: 43.7 to 67.4%), 
91.2% (81.6 to 96.0%), 7.4% (3.1 to 16.2%), and 76.5% (64.8 to 85.2%), respectively [33]. 
Flank- and chuck-associated nodes, which have been reported to bear Salmonella at 3.86% and 
0.35%, respectively, are not removed during carcass dressing and may be present in trimmings 
destined for use in ground beef [34]. Brichta-Harhay, et al. [35] indicated that several Salmonella 
serovars, including S. Anatum, Dublin, Cubana, Typhimurium, and Montevideo were recovered 
from lymph nodes and node-surrounding adipose tissue. A similar study showed that among 
serotypes found in lymph nodes, S. Montevideo (44.0%) and S. Anatum (24.8%) made up the 
majority of recovered Salmonella [33]. This same group also examined Salmonella related to 
lymph nodes and environmental samples and found that S. Kentucky (32.2%), S. Anatum 
(29.9%) and S. Reading (17.2%) made up the majority of recovered Salmonella serovars [33]. In 













Figure 5. A model of Salmonella transmission from feedlot to ground beef. Salmonella in the 
feedlot environment colonizes lymph nodes. Lymph nodes contaminated with Salmonella that are 


















56), feces (n = 18), and hide samples (n = 17) was characterized. Thirty (53.6%), three (16.7%), 
and four (23.5%) isolates of Salmonella from these sample types, respectively, exhibited 
resistance to one or more antibiotics [33]. Beef cattle hides and feces were found to have a 
Salmonella prevalence of 100% and 94.1%, respectively [33]. 
The differences of Salmonella presence and serotypes across multiple lymph nodes 
within the same animal indicate that multiple routes of entry into the lymphoidal system for 
Salmonella may exist [33]. Gragg et al. suggested a transmission route from the environment via 
skin abrasion based on the substantial within-animal diversity of Salmonella [33]. This 
hypothesis was further examined by Edrington et al. via a transdermal Salmonella challenge 
model [36]. Calves were inoculated with Salmonella intra- and/or trans-dermally by applying a 
skin-allergy instrument over various ventral regions of skin [36]. Salmonella was subsequently 
recovered from the drainage of region-specific lymph nodes and the positive result was persistent 
for eight days post-challenge [36]. Another study assessed this transdermal transmission by 
infesting cattle with horn flies that were previously fed with a blood meal containing S. 
Senftenberg [37]. The result from this study indicated that the prolonged exposure to Salmonella 
containing flies had a significant impact on the percentage of culture-positive lymph nodes, as 
8% lymph nodes were Salmonella positive after 5-day exposure, whereas 50% were positive 
after 11-day exposure [37].  
In addition to the transdermal transmission route of Salmonella in cattle feedlots, 
Edrington et al. [38] explored the hypothesis of transmission routes via oral uptake. During a 
fourteen-day experiment period, calves were orally inoculated either with a single high dose of S. 






collected on day 14 for Salmonella identification. The percentage of Salmonella positive lymph 
nodes were greater (P < 0.05) for calves treated single high dose (62.5%) compared to daily low 
dose (12.5%) [38]. However, deprivation of food and water was not shown to increase 
translocation of Salmonella to the lymph nodes [38]. This study provided evidence for a dose-
dependent oral transmission route of Salmonella in the peripheral lymph nodes of cattle [38].  
Although these hypothesized Salmonella transmission routes have not yet been 
comprehensively described, Salmonella within the feedlot environment seems to serve as the 
origin of Salmonella in the lymph nodes of beef cattle (Figure 5). The impact of feedlot 
environmental Salmonella prevalence on transmission during different feed stages was explored 
[39]. In this study, calves at weaning stage (stage 1) continued to be fed at two feedlots with 
positive or negative Salmonella prevalence [40,41].  Calves were harvested for the examination 
of Salmonella prevalence in lymph nodes at the end of stage 2 (stocker), 3 (60 days on feed) and 
4 (120 days on feed). With Salmonella not detecting in lymph nodes of cattle from both 
treatment groups at stage 1, Salmonella prevalence in lymph nodes of cattle fed in Salmonella-
positive feedlot increased as cattle moved into later stages of feeding, at 22%, 78% and 94.4% 
for feeding stages 2, 3 and 4 while cattle fed in the Salmonella-negative feedlot remained 
negative during all feeding stage, implying that environmental Salmonella prevalence during 
feeding operation has influences on prevalence of Salmonella in lymph nodes of cattle at harvest 
[39].  
Other findings indicate variable Salmonella prevalence in cattle feedlots within the same 
geographic region could also differ, possibly due to animal management practices or animal 






resistant Salmonella in cattle lymph nodes and post-harvest environments could also be 
conducted to reduce Salmonella issues in beef industry.  
 
Ground Beef Consumption in the U.S. and Salmonella in Ground Beef  
Figure 2 from USDA-ERS indicates that ground beef holds the largest market share for 
all identifiable beef products [42]. A 2012 report from National Cattlemen’s Beef Association 
(NCBA) showed that although the market share of ground beef consumption has decreased in 
recent decades, it still accounts for 42% of total beef consumption in the United States [43]. This 
translates into the average American consuming 28 pounds per year [42,43] 
Consuming raw or undercooked ground beef is a risk factor for contracting a foodborne 
illness, including Salmonella infection. In one survey, 18% of persons who consumed ground 
beef in the home indicated that they consumed pink/undercooked ground beef [44]. Among all 
citizens, children younger than 18 years old consumed ground beef product most frequently 
(82% of total respondents), in which 7.9 % reported consuming undercooked ground beef. Senior 
age group (> 65 years of age) consumed ground beef least frequently; however, this age group 
reported higher rates of consumption of undercooked ground beef (18.5 % of total respondents) 
[44]. Since younger children are more susceptible to Salmonella [45], and children are 
consuming ground beef more frequently than other age groups [44], public education on safe 
food handling practices and antimicrobial interventions on pre- and post-harvest for beef are 
required to prevent Salmonella transmission.  
In the United States, despite efforts to prevent Salmonella contamination in foods, 






occur [13,45]. From 1973 to 2011, of 1,965 Salmonella foodborne outbreaks reported to CDC, 
beef was the implicated food vehicle in 96 outbreaks [46]. These 96 outbreaks caused 3,684 
illnesses, 318 hospitalizations and five deaths [46]. Ground beef accounts for 23% of total beef 
related outbreaks with median size of 36 illnesses per outbreak [46]. Fifty-nine percent of ground 
beef attributed outbreaks were caused by serotypes Typhimurium and Newport. Ground beef 
emerged as the predominant transmission vehicle to beef related outbreak in 2002. From 2002 to 
2011, ground beef was reported responsible for 45% of beef related outbreaks in the United 
States. Among 14 beef-transmitted outbreaks where antimicrobial resistance data were available, 
ground beef accounted for 3 outbreaks [46]. Although Salmonella prevalence in commercial 
ground beef is low, a survey showed that about 67% Salmonella-positive commercial ground 
beef samples were contaminated with MDR Salmonella [47].  
Reducing use of antibiotics for agricultural production efficiency and developing 
interventions targeting MDR Salmonella are becoming urging needs to prevent ground beef 
attributed Salmonella outbreaks, particularly MDR Salmonella outbreaks.  
 
Bacteriophage: Structure and Infection Pathways 
Bacteriophages (phage) are viruses that infect bacteria, and are the most abundant form of 
life on earth, estimated to number some 1031 to 1032 organisms in total [48,49]. Phage are 
ubiquitous in natural environments such as such soil, fresh water, open ocean, and are present in 
plants and animals as a part of their normal flora. Phages are non-pathogenic to humans and are 






A phage virion consists of a single-stranded or double stranded DNA or RNA genome 
and a protein or lipoprotein coat [50,51].  Over 96% of described phages belong to the order 
Caudovirales or tailed dsDNA phages [50,51]. The heads of Caudovirales are icosahedral in 
shape and in some cases elongated. Caudovirales consists three major families with distinct tail 
morphologies: Myoviridae with contractile tails, Siphoviridae with flexible non-contractile tails 
and Podoviridae with short stubby tails [52].  
Phage infection starts with adsorption of the phage to its host, where specialized 
adsorption structures, such as tail fibers and spikes, bind to specific surface receptor on the target 
bacteria such as outer membrane proteins, flagellum, and liposaccharides [50]. Phage DNA is 
ejected into the host bacterium following the initial attachment. Based on their infection cycles, 
Caudovirales are divided into two major groups: virulent and temperate [50]. Virulent phages 
obligately undergo a lytic life cycle upon DNA injection while temperate phages, also known as 
lysogenic phages, are capable of incorporating their genomes into that of the host cell and 
coexisting with the host in a quiescent state [52].  
After its injecting DNA into the bacterial cell, virulent phages prevent bacterial 
transcription and replication and direct the host cell to produce more copies of the phage genome 
and capsid components (Figure 6) [53]. After phage genome replication and protein synthesis, 
phage particles are assembled to new virions. New virions are released upon disrupting the 
bacterial cell wall by the combined action of an inner membrane pore-forming holin protein, a 






In contrast, when temperate phages infect the cell a lysis-lysogeny decision is made. If it follows 
the lysogenic pathway, the phage turns off viral transcription, and its DNA is inserted into the 
host chromosome via a phage-encoded integrase or exists separately as an episomal  
element and replicates together with the host chromosome as the host cell divides (Figure 7) 
[50]. When a temperate phage undergoes its lytic cycle in a process called induction, the phage 
replicates within the host cell to produce new progeny and lyse the cell upon release of new 
virions in the same manner as virulent phage (Figure 7) [50].  
 
Bacteriophage as an Antimicrobial Intervention in Agriculture 
The antimicrobial activity of bacteriophage was discovered independently by Frederick 
Twort in 1915 and Felix d'Herelle in 1917 [55]. The therapeutic application for treating human 
bacterial infections was hypothesized by Felix d'Herelle during an outbreak of severe Shigella  
hemorrhagic dysentery among French troops stationed at Maisons-Laffitte [55]. He filtered the 
bacterium from patients’ fecal samples and combined the filtrates with Shigella strains isolated 
from the patients. After incubation, a clear area was observed on the agar culture, which were 
later called plaques [55]. d’Herelle also ran a small clinical trial treating young children suffering 
from bacterial dysentery with phage preparations and observed recovery within 24 hours [56]. 
Phage therapy attracted interest from pharmaceutical companies, including Eli Lilly and 







Figure 6. Life cycle of virulent phages.  Lytic phage adsorbs to its host and ejects its DNA (blue) 
into the cell. The host metabolism is redirected to the replication of new virion components. New 













   
Figure 7. Life cycle of temperate phages. A decision between the lytic cycle and lysogenic cycle 
is determined by the phage shortly after infecting the cell. In the lytic cycle (black arrows), new 
phage particles are produced and released upon lysis of the host cell. In the lysogenic cycle 
(green arrows), the phage DNA (blue) is incorporated into the host chromosome (red) and 















preparations for clinical applications [56]. However, in the 1940s and 1950s, due to the 
discovery and later use of antibiotics, along with doubts on efficiency of phage therapy, 
bacteriophage therapy research discontinued in the West [57]. Nevertheless, phage therapy 
continued to develop in Eastern Europe and the former Soviet Union, including work at several 
institutions such as the Eliava Institute of Bacteriophage, Microbiology and Virology (Tbilisi, 
Georgia) and the Hirszfeld Institute of Immunology and Experimental Therapy (Wroclaw, 
Poland) [57]. 
The spread of antibiotic resistant bacteria has become a worldwide threat, which has 
renewed the interest in exploring bacteriophage as a potential alternative to control pathogenic 
bacteria in Western countries [58]. Garcia et al. [57] suggested that phage can be addressed to all 
stages of food production, from “farm to fork”, to prevent foodborne infections due to 
advantages that phages offered as biocontrol agents [59]. First, being able to target bacterial 
hosts with high specificity by recognizing unique bacterial surface structure, antimicrobial 
treatments with phages leave the remaining microbiota unharmed. This property favors phages 
over broad-spectrum antimicrobials that could cause collateral damage to the microbial floral 
[59]. Second, purified phages do not alter flavor, color, aroma and nutritional content of food 
product and have little inherent toxicity due to their natural composition of nucleic acids and 
proteins. In addition, phage-containing products are considered “clean label” because of their 
wholesomeness of ingredients and lack of artificial ingredients or allergens [60].  
Several phage-based commercial products have gained approval for use by the U.S. 
Department of Agriculture (USDA), Food and Drug Administration (FDA) and Environmental 






antimicrobial intervention. EcoShieldTM, a bacteriophage preparation produced by Intralytix Inc., 
obtained regulatory approval from the FDA through a “Food Contact Notification” (FCN No. 
1018) for use on raw meat cuts and trim to control E. coli O157:H7 prior to grinding [61]. The 
FDA has also approved ListShieldTM, another phage-based product from Intralytix Inc., for 
application on ready-to-eat (RTE) meat and poultry products for Listeria monocytogenes 
reduction [58]. SalmoFreshTM  from the same company gained approval with generally 
recognized as safe (GRAS) for application on poultry products for reducing Salmonella enterica 
population (GRN No. 435.). AgriPhageTM, a phage cocktail produced by Phagelux Inc. 
(previously OmniLytics Inc.), gained approval from the Environmental Protection Agency for 
application on growing produce in the field to reduce plant pathogenic bacteria [57]. Finalyse®, 
produced by Passport Food Safety Solutions, Inc., was approved for application to the hides of 
beef cattle to reduce E. coli O157:H7 prior to slaughter [59]. This product was recommended to 
be applied via a walk-through misting system designed to fully cover cattle before harvest. 
Micreos Food Safety (Wagentingen, Netherlands) has launched two products, PhageGuard 
ListexTM and PhageGuard STM, which has been approved as GRAS and certified as useful in 
organic food production. Similar to ListShieldTM, PhageGuard ListexTM is used as a processing 
aid for control of L. monocytogenes. According to Microes, PhageGuard STM is intended to be 
used as a spray on food post-harvest at points of contamination during processing and is 
expected to achieve 1.0 – 3.0 log10 reduction of salmonellae.  
Prevalence and antimicrobial activities of phages in the pre-harvest environment has been 
studied. Callaway et al. has shown that phages targeting E. coli O157:H7 were widely distributed 






antimicrobial interventions against E. coli O157:H7 and demonstrated their efficacy for 
eliminating E. coli O157:H7 in the ceca and rectums of sheep [63,64]. Phage have also been 
shown to be effective in controlling a wide variety of pathogens in other animal models, 
including Salmonella in poultry and E. coli O157:H7 [65] in cattle [63]. After inoculation of E. 
coli O157:H7 via rectal application, Sheng et al. administrated 25 mL bacteriophage mixture of 
SH1 and KH1 at concentration 1010 PFU/mL via direct anal application with a syringe and via 
additional oral intake from drinking water at average concentration ~2.4 PFU/mL [63]. The 
administration of mixed phages were able to achieve a reduction of 2.4 log10 CFU/swab 
immediately after the treatment on day 1 and continued to suppress bacterial population 
throughout the 16-day sample period [63]. Sukumaran et al. [65] conducted a study on reduction 
of Salmonella on chicken meat that provided peer review on SalmoFreshTM. (Instralytix Inc., 
USA). In this study, the commercial bacteriophage preparation at concentration 9log10 PFU/mL 
was able to achieve 2log10 CFU/mL reduction in diluent homogenized with samples during a 7-
day refrigerated storage period [65].  
 
Lytic Salmonella Phages 
After reviewing the literature up to 2005, Abedon and Ackermann described 170 named 
Salmonella phages [53,66].  Among phages in order Caudovirales, 44 Myoviridae, 65 
Siphoviridae and 63 Podoviridae were summarized in this list [53,66].  
In the family of Myoviridae, lytic Salmonella phages mainly fall into four genera, 






phages) and T4likevirus (T4-like phages), with an exception, phage SPN3US, that is 
uncategorized [53].  
The first phenotypic characterization of Vi phage was conducted by Ackermann el al. in 
1970 and it was further characterized at the molecular level by Pickard in 2010 [67,68]. Genome 
sizes of ViI-like phages are approximately 157 kb with a GC content of 44.5% [69]. Morphology 
of Viunalikevirus features icosahedral heads of 90 nm and contractile tails of 110 x 18 nm [69]. 
A unique characteristic of ViI-like phages is that this genus contains a conserved maturation-
adhesion tail spike protein that recognizes the Vi exopolysaccharide capsule as the receptor [68]. 
Up to 2014, there were seven Salmonella phages of this genus that have been sequenced and the 
genome identities of these phages revealed >59% identity [53].  
Felixounalikevirus were first known as phage O1 that were originally isolated by Felix 
and Callow [70]. Phage FelixO1 has an icosahedral head of 73 nm and a contractile tail of 17 x 
113 nm that contains six straight tail fibers folded along the tail [71]. Within this genus, seven 
phages capable of infecting Salmonella are sequenced, and their genomic characteristics include 
a genomic size of 86 kb and a GC content of 39%. In addition, they were found to have >20 
tRNAs and homing endonuclease in their genomes [71]. Broad host ranges are generally found 
in this genus, with phage FelixO1 reportedly capable of infecting 98.2 % (640/652) tested 
Salmonella strains at concentration 1012 PFU/mL [72].  
V5likevirus was proposed as a genus with two members targeting Salmonella, five 
targeting E. coli and one targeting Cronobacter sakazakii. V5-like phages are found to have 
genomic size ranging from 136 to 148 kb and GC content ranging from 37.4% to 46.3% [53]. 






and contractile tail of 120 x 18 nm. The receptor of phage PVP-SE1 was recognized as the inner 
core of LPS, and this relatively conserved receptor region explains the broad host range of this 
phage [73]. 
Phages in the genus of T4likevirus are related to coliphage T4, but they are generally 
diverse ecologically, morphologically, genomically, and proteomically [74,75]. Two Salmonella 
phages within this genus, STML-198 [76] and S16 [77], were previously sequenced while 
molecular level analysis was conducted only in phage S16. This phage shares 60% homologous 
proteins with T4 and it has a genome of 160kb with GC-ratio of 36.9% [77]. Morphologically, its 
head is elongated, 117 nm in length and 91 nm in width [77]. This phage was found to have 
broad host range, especially in Salmonella species, infecting 76% (96/126) of isolates tested 
while resistant other species within the family of Enterobacteriaceae tested [77]. Authors 
identified Salmonella outer membrane protein OmpC as the primary receptor and LPS as the 
secondary receptor of phage S16 [77].  
Within the family of Myoviridae, a jumbo phage SPN3US was sequenced and showed 
little homology to any other phages in the NCBI database [78]. The majority of the genome  
(>79%) was annotated as hypothetical protein and the putative functions that were annotated in 
phage S16 were related to phage structure (capsid, tail, terminase), replication and transcription 
(helicase, RNA polymerase), and lysis (endolysin) [78].  
In the family of Siphoviridae, five major genura were identified among Salmonella 
phages that were sequenced and published [53]. 
Salmonella phages SPC35  [79] and EPS7 [80] are members of the genus T5likevirus, in 






genus [81]. Salmonella phages in the family of T5likevirus generally have genome of ~110kb 
with GC-ration of 39%. They are generally found to have more than 20 tRNAs in their genome 
[53]. They typically have an icosahedral head of 70 nm in diameter and long noncontractile tails 
of 185 nm in length [81]. Both phages SPC35 and EPS7 were found to utilize Salmonella outer 
membrane protein BtuB as their receptors [79,80]. 
Salmonella phages within the family of Jerseylikeviruses were found to be related to 
phage Jersey, a tying phage that has been used in the S. Paratyphi B tying scheme [82]. Genomic 
characteristics of this genus include a genome size of 42kb and a GC-ration of 49%.  
Jerseylikeviruses generally have icosahedral heads of 64 nm, a long noncontractile tail of 120x7 
nm and a baseplate of 20 nm with spikes [83]. Salmonella phages in this genus were found to 
have high level of nucleotide identity up to 93%, which is a distinct feature of phages of this 
genus [83].  
Salmonella phages in the family of Tunalikevirus are related to phage T1, a phage that 
was isolated by Milislav Demerec and later intensively study by Max Delbrück [84]. Due to the 
ability of T1 to form aerosol, T1 contaminations continue to be a problem in laboratory working 
with E.coli [53]. Morphological characteristics of Tunalikevirus include a icosahedral head of 60 
nm and a long noncontractile tail of 200 nm that are terminated by four fibers [53]. T1-like 
phages commonly have a genome size of 50.7 kb and a GC-ratio of 45.6% [85]. The genome is 
terminally redundant and circularly permuted [85].  
The original phage Chi in the family of Chilikevirus was isolated in 1935 by Sertic and 
Boulgakov [86]. The most distinct property of phages in this family is its specificity to motile 






Schade et al. suggested that phage Chi attaches to the filament of bacterial flagellum by its tail 
fiber but the actual receptor was located at the base of flagellum [87]. Chi-like phages have 
icosahedral head with diameter ranging from 65.0 – 67.5 nm and long flexible tail with size 220 
– 230 nm x 12.5 – 14 nm [88]. Phage Chi has a genome size of 59.6kb and 56.6% GC content 
[89]. Phage Chi and its related phage SPN19 and iEPS5 share high level of DNA and protein 
identity of 90% and 93%, respectively [53].  
Unclassified Salmonella phages in the family of Siphoviridae include a group of closely-
related phages isolated by Switt et al. [90]. Genomic characteristics of these phages include a 
genome size of 55kb and GC content of 51%. The most distinct property of this genus is their 
very narrow host range [90]. Among 25 Salmonella serovars tested, these phages were only able 
to infect one strains from the serovar of S. Cerro [90]. They are in the process of proposing a new 
genus of Sp03unalikevirus to ICTV [53]. 
The family of Podoviridae contains Phieco32likevirus, N4likevirus and a super-group 
Autographivirinae that includes T7likevirus and Sp6likevirus [53].  
Phages in the subfamily of Autographivirinae generally process a genome size of 
approximately 40kb and a GC-ration of 47% [91,92]. Coliphage T7, the type phage in the genus 
of T7likevirus, is one of the most well-characterized virulent phage and one of the very first 
phage that were completely sequenced [91]. Another two phages, SP6 and K1-5, process direct 
terminal repeats of 174bp and 245bp, respectively [92]. The three phages mentioned show low 
level of homology in their genome, and therefore, suggested by Scholl et al., diverged a long 






Phages in the genus of Phieco32likevirus process morphological characteristics including 
a unusual elongated head (145 nm × 44 nm) and a short tail  (13 nm x 8 nm) terminated by tail 
fibers [93]. Up to 2011, there was only one Salmonella phage, phage 7-11, that was sequenced 
and analyzed in this genus [94]. Phage 7-11 possesses a genome size of 89.9kb and a GC-ratio of 
44.1%. Although phage 7-11 was classified as a member of Phieco32likevirus, its genome 
showed little homology with phage phiEco32 (32% homologous protein) [94]. 
In 2013, Switt et al. added two Salmonella phages, FSL SP-058 and FSL SP-076, to the 
genus of N4likevirus [90]. Coliphage N4 processes morphological characteristics including a 
icosahedral head of 70 nm in diameter and short tail fiver between the head and tail [95]. Phages 
from this genus generally have a genome of 72kb in size and a GC-ration of 39.5% , encoding 10 
tRNAs [90]. Phage FSL SP-058 and FSL SP-076  are closely related, with a high protein identity 
of 89% [90]. 
 
Current Status of Phage Isolation 
 During 2013 – 2016, three phage isolation were performed. Table 1 processes 
information including their identification, bacterial host, morphology, sequence status, 
annotation status, phage type and additional information provided. Phage isolated from previous 
study conducted by Xie et al. [41] were describe in two published sources [96,97]. Additional 











Table 1. Bacteriophage information  
 
Phage ID Host Morphology Sequencing Annotation Rename Phage Type Note
Intesti 1 S.  Typhimurium LT2 Myo Yes Yes Mushroom Felix O1 Genome Submitted 
Intesti 3 S . Typhimurium LT2 Sipho Yes Yes Shivani T5-like Genome Submitted 
pk2 S.  Typhimurium LT2 Sipho Yes Yes Seelong Chi-like
Intesti3(E.coli) E. coli  K12 Podo Yes Yes Peach T7-like
Intesti1(E.coli) E. coli  K12 Myo Yes Yes Mishka N/A
3 S.  Anatum FC1033C3 Sipho Yes Yes Sasha 9NA-Like Genome Submitted 
5 S.  Anatum S2029C2 Sipho Yes Yes Season5 9NA-Like
6 S.  Typhimurium LT2 Sipho Yes Yes Season6 Chi-Like
9 S . Anatum FC1033C3 Sipho Yes Yes Sergei 9NA-Like Genome Submitted 
12 S.  Newport USDA2 Sipho Yes Yes Season12 Chi-Like
13 S.  Typhimurium LT2 Sipho Yes Yes Season13 Chi-Like
15 S . Montevideo USDA3 Myo Yes Yes Munch Novel Big Head Myo
17 S.  Anatum S2028C1 Myo Yes Yes Minion Novel Big Head Myo
21 S. Muenchen FD1001A1 Myo No Yes Mecon Cannot be sequenced
24 S. Anatum USDA4 Sipho Yes Yes Season24 9NA-Like
25 S.  Anatum S2028C1 Myo Yes Yes Morel Novel Big Head Myo
27A S.  Anatum FC1033C3 Sipho Yes Yes Season27A Chi-Like
28 S . Montevideo USDA3 Myo Yes No Novel Big Head Myo Cannot be recovered from parent stock
MIS1-NP1 S.  Newport USDA2 Myo No No
MIS1-LT2 S.  Typhimurium LT2 Sipho Yes Yes Novol phage type
MIS3-3117 S.  Heidelberg 3117 Myo Yes Yes Meda Felix O1
MIS4-UE S . Enteritidis UE Sipho Yes No FSL-SP-101 Similar to Moerno Switt phage
SL-Monte2 S.  Anatum S2029C2 Sipho Yes No 9NA-like
SE-Anatum S.  Anatum S2028C1 Sipho Yes No FSL-SP-031 Similar to Moerno Switt phage
SL-Ken S.  Anatum FC1033C3 Sipho Yes Yes 9NA-like
1ww-UE S . Enteritidis UE Myo No No
2ww-3119 S.  Newport 3119 Myo Yes Yes Melville S16-like
5ww-LT2 S.  Typhimurium LT2 Sipho Yes Yes Chi-like
Sw1-3003 S.  Typhimurium 3003 Myo Yes Yes T4-like (mostly structural) Silimiar to one of EcoShield phage
Sw2-Ken S.  Anatum FC1033C3 Sipho Yes Yes T5-like
Sw2-Monte2 S.  Anatum S2029C2 Myo No No
Sw2-NP2 S.  Newport 10-014 Myo No No
SW4-UEa S . Enteritidis UE Myo Yes No T5-like?? Needed to be resequenced
SW1-LT2 S.  Typhimurium LT2 Sipho Yes No Chi-Like






















DEVELOPMENT AND VALIDATION OF A MICROTITER PLATE-BASED ASSAY FOR 
DETERMINATION OF BACTERIOPHAGE HOST RANGE AND VIRULENCE 
 
Introduction 
The growing threat of antibiotic resistance has led to increased calls for new 
antimicrobials to control bacterial pathogens and treat infectious diseases [98-100]. 
Bacteriophages are the natural predators of bacteria and were used to treat bacterial infections in 
the pre-antibiotic era [101,102]. Phages have re-emerged as an attractive alternative to combat 
antibiotic resistant bacteria in recent decades [103]. The abundance of phages in natural 
environments makes the discovery and isolation process rather simple [104,105], but screening 
and selecting the right phages is crucial for achieving successful therapeutic outcomes. One 
advantage of phages as therapeutics is their host specificity [106,107] and the ability of most 
phages to infect only a relatively narrow range of closely related bacterial strains limits its 
impact on normal bacterial flora [106,108]. The drawback to host specificity is the limitation on 
treatment outcomes prior to identifying bacterial susceptibility of particular phages [106]. 
The ability of a phage to infect and lyse th1e target bacterial strain is generally agreed to 
be a basic requirement for successful phage therapy [109-111]. Phage virulence, which is defined 
as the ability of a phage to control the growth of its host in culture, may also be an indicator of 
                                               
*Reprinted with permission from “Development and Validation of a Microtiter Plate-Based 
Assay for Determination of Bacteriophage Host Range and Virulence” Xie, Y., Wahab, L., 







phage utility [112-114]. The phage host range is affected by a number of factors [115,116]. The 
phage must be able to adsorb to the cell surface in order to initiate infection and the absence or 
masking of a compatible cell surface receptor will prevent this initial interaction. With successful 
phage adsorption, the entry of phage DNA to a bacterial cell could be blocked by superinfection 
exclusion systems or the absence of required accessory proteins. Restriction-modification and 
CRISPR systems block infection by degrading phage DNA shortly after it arrives in the cell 
cytoplasm and abortive infection systems that are triggered on phage infection result in host cell 
death before new phages can be produced. All of these factors together limit the host ranges of 
naturally recurring phages and can affect the results of experiments designed to determine the 
phage host range. Given the increased interest in phage therapy, there is a need for in vitro assays 
that can be used to help determine the suitability of phages for in vivo application [114,117]. 
The definitions and outcomes of the phage host range vary between testing 
methodologies [107,118]. To claim a host is “sensitive” to a phage may mean that the phage is 
able to infect, produce progeny, and lyse its host or simply that the host cell dies following phage 
infection. The spot test is often used to determine the host range by measuring bacterial killing 
by applying high-titer phage lysates to agar lawns inoculated with host bacteria [119]. Applying 
phage only at high titer can fail to distinguish between the ability of phage to replicate within or 
simply kill the test strain since a similar result could be produced through  phage infection and 
lysis, abortive infection, or lysis from without [107]. Spotting single dilutions of lower phage 
concentrations has also been a common host range method [120,121]. In this approach, the phage 
is diluted to a routine test dilution (RTD), which is typically defined as the lowest phage dilution 






spotting a high-titer phage lysate since a level of productive phage infection is required to 
produce a signal. Another commonly used method for testing the host range is measuring phage 
efficiency of plating (EOP), which counts the number of plaques formed by a phage on a test 
strain relative to its titer observed on its original host [107,119]. Plaque formation is a better 
indicator of productive phage infection since it is the result of multiple rounds of infection, lysis, 
and release of progeny. Mirzaei and Nilsson [122] compared the results from spotting high titer 
lysates and measuring EOP in phages infecting E. coli and Salmonella. The researchers 
determined that the high-titer spotting method often overestimated the phage host range and 
virulence. While the production of clearing zones in bacterial lawns following application of 
high-titer phage lysate may overestimate phage sensitivity, the inability of a phage to form 
visible plaques in a bacterial lawn does not necessarily mean a lack of productive infection. 
Plaque formation is a dynamic process and differences in phage latent period, burst size, 
diffusion rate, and growth of the host can all affect plaque size and visibility [107,123]. 
Observation of phage infection in a liquid culture could serve as an alternative method for 
measuring the phage host range and virulence for phages that are incapable of making observable 
plaques [107]. Henry, Lavigne and Debarbieux [112] analyzed phage virulence in Pseudomonas 
aeruginosa broth culture and were able to differentiate between phages based on differences in 
the culture optical density over time. In this case, all phages studied were already known to infect 
the host strain by EOP-type assays. However, performing liquid culture assays in traditional 
culture flasks is time and labor intensive and limits the throughput of the method. 
Minimum inhibitory concentration (MIC) assays are typically used to simultaneously test 






the standard 96-well microtiter plate [124]. In this approach, a culture of the test organism is 
inoculated at a low density (~105–106 CFU/mL) into wells containing graded concentrations of 
antimicrobial compounds in broth medium. The presence or absence of bacterial growth is 
scored following a fixed period of incubation. The culture containing the lowest concentration of 
antimicrobial that inhibits bacterial growth is termed the MIC of the compound for that 
organism. This approach has been expanded to estimate the performance of other biocidal 
compounds in food safety applications [125,126]. Endpoint MIC-like assays have been adopted 
to measure the host range and virulence of phages infecting enterohemorrhagic E. coli [127] and 
phages of S. aureus, E. coli, and Salmonella [128]. However, such endpoint assays can yield 
false-negative results if phage resistance acquired during the course of the assay results in culture 
turbidity at the time of end-point determination [107]. Phages that are capable of infecting the 
host but do not replicate well in liquid culture could fail to clear the culture. This also leads to a 
false negative at end point determination [107]. The Bioscreen-C growth analysis system has 
been used to obtain real-time measurement of culture optical density in the presence of phages to 
determine phage virulence [129] and host range [130-132]. The Bioscreen-C system can provide 
high-resolution monitoring of culture optical densities over time and these assays have been 
evaluated qualitatively or by measuring the inflection of the growth curve at set time points. The 
measurement of bacterial respiration in the presence of phage in liquid culture has also been used 
to simultaneously determine phage host range and virulence in a high-throughput, 96-well format 
[133]. In this system, the production of a colorimetric signal by reducing a tetrazolium dye is 






In the current study, a liquid culture-based host range method is developed, which 
continuously monitors bacterial growth in the presence of phage in a standard 96-well format and 
this method is compared to the results from conventional agar overlay spot assays. The intent of 
this methodology is to determine the phage host range, virulence, and bacterial resistance 
development in a single high-throughput format by using the features of an automated plate 
reader to monitor the culture optical density over time in an incubating, aerated environment. 
Growth responses are quantified by integrating the growth curve over the entire experiment, 
which allows them to be directly compared. This microtiter plate host range assay is expected to 
serve as an alternative host range method and can potentially be a more sensitive predictor of 
virulence of phages by providing more information on bacterial inhibition with high resolution 
between bacterial strains. 
 
Materials and Methods 
1. Bacterial Strains and Culture Conditions 
A panel of 20 Salmonella strains from various sources representing 11 serovars were 
used in this study, which is shown in Table 2. All bacteria and phages were cultured in tryptic 
soy broth (TSB) (Becton-Dickinson, Franklin Lakes, NJ, USA) or tryptic soy agar (TSB plus 
1.5% w/v Bacto agar (Becton-Dickinson)) aerobically at 37 °C.  
2. Bacteriophage Strains and Culture Conditions 
Phage FelixO1 was obtained from the Salmonella Genetic Stock Center (University of 
Calgary, Calgary, AB, Canada) and propagated on the S. Typhimurium strain LT2. Twelve of the 






Table 2. Bacterial strains used in this study and their origins. Reprinted from Xie et al., 2018 [96]. 
Strains Serovars Sources/References 
USDA4 Anatum T. Edrington (USDA)/[41] 
FC1033C3 Anatum Cattle Feedlot Environment/[41] 
S2029C2 Anatum Cattle Feedlot Environment/[41] 
S2028C1 Anatum Cattle Feedlot Environment/[41] 
FD1001A1 Muenchen Cattle Feedlot Environment/[41] 
H2006-1 Cerro Cattle Feedlot Environment/[40] 
08-022 Dublin S. Lawhon (Texas A&M Veterinary Medicine) 
SGSC 2475 Enteritidis Salmonella Genetic Stock Centre/(University of Calgary, CA)/[134] 
3115 Enteritidis T. M. Taylor (Texas A&M University) 
SGSC 2480 Heidelberg Salmonella Genetic Stock Centre (University of Calgary, CA)/[134] 
3117 Heidelberg K. Cummings (Texas A&M Veterinary Medicine) 
USDA3 Montevideo T. Edrington (USDA)/[41] 
H1042-3 Montevideo Cattle Feedlot Environment/[40] 
USDA2 Newport T. Edrington (USDA)/[41] 
10-014 Newport S. Lawhon (Texas A&M Veterinary Medicine) 
330-1 Reading S. Lawhon (Texas A&M Veterinary Medicine) 
USDA1 Typhimurium T. Edrington (USDA)/[41] 
3116 Typhimurium T. M. Taylor (Texas A&M University) 
LT2 Typhimurium American Type Culture Collection/ATCC 19585 
USDA5 Kentucky T. Edrington (USDA) 
 
 
environmental samples described previously [41]. The 72 enrichments were pooled by pen, 
feedlot, and enrichment strains to produce 18 composite samples and enriched again against the 
same two sets of mixed bacterial hosts, which was described previously [41]. Two additional 
phages known as Sw2 and Melville were isolated in 2016 from a municipal wastewater influent 
sample enriched for phage using the same mixed-host panel as above. Each enrichment was 
serially diluted and plated to soft agar lawns inoculated with each individual enrichment host. 
Additionally, individual plaques were picked and purified by subculturing three times. Plaques 
picked from the third subculture of each bacteriophage were used to produce high-titer phage 
stocks by using the confluent plate lysate method [135]. Soft agar overlays were prepared as 






Tris-HCl pH 7.4, 8 mM MgSO4, 0.01% w/v gelatin) at 4 °C. Phages used in this study and their 
propagation hosts are summarized in Table 3. 
 
 
Table 3. Bacteriophages used in this study, their propagation hosts, and their origins. Reprinted 
from Xie et al., 2018 [96]. 
Phages Propagation Host Source 
Sasha FC1033C3 Cattle Feedlot Environment/[41] 
Season5 S2029C2 Cattle Feedlot Environment/[41] 
Season6 LT2 Cattle Feedlot Environment/[41] 
Sergei FC1033C3 Cattle Feedlot Environment/[41] 
Season12 USDA2 Cattle Feedlot Environment/[41] 
Season13 LT2 Cattle Feedlot Environment/[41] 
Munch USDA3 Cattle Feedlot Environment/[41] 
Minion S2028C1 Cattle Feedlot Environment/[41] 
Mecon FD1001A1 Cattle Feedlot Environment/[41] 
Season24 USDA4 Cattle Feedlot Environment/[41] 
Morel S2028C1 Cattle Feedlot Environment/[41] 
Season27A FC1033C3 Cattle Feedlot Environment/[41] 
Sw2 FC1033C3 Municipal wastewater influent, TX 
FelixO1 LT2 Salmonella Genetic Stock Centre (University of Calgary, CA) 




3. Phage Host Range Agar Overlay Spot Assay 
Fresh (~18 h) overnight cultures of bacterial strains were prepared in TSB, subcultured 
1:100 in fresh TSB, and grown to OD550 ~0.5. Agar overlays were prepared by inoculating 4 mL 
of molten top agar (10 g L−1 Bacto tryptone (Becton-Dickinson), 10 g L−1 NaCl, 5 g L−1 Bacto 
agar) with 100 µL of OD550 ~0.5 host culture and then poured over TSA plates. Lysates of each 
phage were ten-fold serial diluted and 10 µL of each dilution was spotted onto the overlay 






this study, the routine test dilution (RTD) [120] was defined as the first dilution at which the 
phage produced countable plaques on a lawn of their propagation host. Each phage lysate was 
adjusted with phage buffer to achieve the RTD and 100× RTD, spotted on the overlays of the 
panel of 20 Salmonella strains, and incubated at 37 °C overnight. Spot assay results of each 
phage-bacterium combination were scored using the following parameters. Production of >50% 
of the plaques formed on the propagation host at RTD = 4; production of <50% of the number of 
plaques formed on the propagation host at RTD = 3; production of a confluent zone of lysis but 
no individual plaques at 100× RTD = 2; production of individual plaques at 100× RTD = 1; and 
no plaque formation at either dilution was scored as 0. 
4. Methodology Development for the Microtiter Plate Host Range Assay 
A subset of four bacterial strains (S. Anatum strain FC1033C3, S. Newport strain 
USDA2, S.Typhimurium strain USDA1, and S. Enteritidis strain SGSC 2475) and four phages 
(Sasha, Season12, Munch, and Sw2) were selected to develop the parameters for the microtiter 
plate liquid-culture host range assay. Different initial bacterial inoculum levels were tested in 
combination with phages at starting concentrations of 106 to 108 PFU/mL. The low inoculum 
condition (~105 CFU/mL) was achieved by adjusting fresh overnight cultures OD550nm ~0.5 and 
diluting 1000-fold in TSB. For the high inoculum condition, fresh overnight cultures were 
adjusted with TSB to OD550nm ~0.1 to achieve a concentration of ~108 CFU/mL. Phage lysates 
were titered and adjusted to concentrations of 107, 108, and 109 PFU/mL with phage buffer. For 
each assay, 180 µL of adjusted bacterial inocula in TSB were mixed with 20 µL of phage in 
sterile, untreated Falcon (Corning) 96-well transparent plates to achieve final phage 






°C with double orbital shaking in a Tecan Spark 10 M plate reader (Tecan Group Ltd., 
Männedorf, Switzerland) and growth was monitored by measuring OD550nm at 30-min intervals 
for 12 h, which results in 25 total time points including the initial (time 0) measurement. Growth 
curves were obtained by plotting OD after baseline adjustment against time. All assays were 
performed with three biological replicates. 
5. Analysis of Microtiter Plate Host Range Assay Data 
Based on the results obtained from the above pilot experiments, the high bacterial 
inoculum (~108 CFU/mL) condition with phages at 106 and 108 PFU/mL was used to assess the 
phage host range and virulence for the rest of the collection. Preparation of bacterial inoculum, 
phage, and measurement parameters were as described above in triplicate. To facilitate data 
analysis, the growth patterns observed in each assay were distilled into single numerical values 
by measuring the area under each curve for both positive control and phage treatments by using 
the equation below. 
 
where OD were measured at 550 nm at 30-min time points i. For example, the OD550nm measured 
at time timepoint i = 3 (60 min into the experiment) is added to the OD550nm measured at i = 4 (90 
min) and divided by 2 to give the OD550nm value for the center of the interval. Each of these 
values are combined over the entire experiment to give a total area under the growth curve. Since 
all time intervals are equal in this procedure, time is not explicitly required in this calculation. 
The areas under the curve calculated in Equation (1) are normalized as percentages of the area 















× 100 (2) 
  
where the Areapositive control and Areaphage treatment are the areas under each curve obtained from 
Equation (1). The liquid assay score is equal to the area between the positive control curve and 
phage treatment curve, divided by the total area below positive control curve, and multiplied by  
100. An illustration of the derivation of the assay score is shown in Figure 8. In this way, the 
assay scores represent how well phages are able to suppress bacterial growth during the 12-h 
experiment. The average values calculated by Equation (2) across triplicate biological replicates 
(n = 3) were used as the assay scores for all phage-host combinations.Comparisons between the 
microtiter plate assay and spotting assay results for each phage-host combination were carried 
out by normalizing the results of both methods to the result obtained for the phage propagation 
host and calculating the difference using the equation below. 
 
The calculated values of difference demonstrate the agreement or disagreement between 
two host range methods with greater positive values, which indicates higher phage sensitivity 
measured by the spot assay, and greater negative values indicate higher sensitivity measured by 
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Figure 8. An illustration of the liquid assay score is derived by Equation (2). Reprinted from Xie 
et al., 2018 [96].The equation calculates the area (grey) between the positive control (solid line) 
and the phage-inoculated culture (dashed line) and expresses this as a percentage of the total area 
under the positive control curve. No inhibition of bacterial growth (solid and dashed lines overlap) 
results in a score of zero and completes the absence of growth in the phage-inoculated culture 




























scores at different phage concentrations to determine if one condition yielded higher agreement 
with the spotting assay. 
6. Statistical Analysis 
Statistical analyses were performed using JMP Pro v12 (SAS Inst. Inc., Cary, NC, USA). 
The Shapiro-Wilk Test was performed to determine the normality of distribution for microtiter 
assay scores by concentrations across all tested bacterial strains. Significantly differing assay 
scores by concentrations were separated by using the Wilcoxon/Kruskal Wallis Test (p < 0.05). 
 
Results and Discussion 
1. Measurement of Phage Host Range by Traditional Spot Assay 
The host ranges of 15 Salmonella phages against a panel of 20 Salmonella strains, which 
is measured by a traditional spot assay, are shown in Figure 9. In this method, phages adjusted to 
a consistent routine test dilution (RTD) were spotted to agar overlays inoculated with each 
bacterial test strain and observed for the formation of plaques. A scoring system was used to 
summarize plaque formation by spotting the phage lysates at the RTD and at 100× RTD. A score 
of 4 corresponds to phage efficiency of plating (EOP, the number of plaques observed on the test 
strain divided by the number of plaques observed on the phage host) of ~0.5 to 1, a score of 3 
represents an EOP of ~0.05–0.5, a score of 2 represents an EOP of ~0.01–0.05, and a score of 1 
represents an EOP of ~0.0002–0.01. Scores of 0 represent phage EOP of less than ~0.0002. The 
Salmonella strain panel used in this study was diverse and represents 11 serotypes that are 
commonly associated with human disease or animal carriage [134]. The host ranges of the tested 







Figure 9. The host range of 15 Salmonella phages against 20 Salmonella strains were measured 
by spotting on soft agar overlays. Reprinted from Xie et al., 2018 [96]. Phages were plated at the 
routine test dilution (RTD and determined as the first tenfold serial dilution of phage lysate that 
formed countable plaques on lawns of its own host) and 100× the RTD. Phage were tested and 
scored on the following criteria: phage forming >50% of the number of plaques formed on its 
host strain at its RTD = 4; phage forming 5% to 50% of the number of plaques formed on its host 
strain at its RTD = 3; phage forming a zone of confluent lysis but no individual plaques at 100× 
RTD = 2; phage forming individual plaques at 100× RTD = 1; and no plaque or clearing 
formation at either dilution = 0. The scores from three replicate experiments were averaged. To 
aid the reader, cells are shaded with stronger color intensity indicating a greater score. Boxed 
cells indicate the initial isolation and propagation host of the phage. For clarity, all values are 
displayed to one significant figure unless a non-zero value is present at the first decimal place. 
 































































































































































































Sasha 4 4 4 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Season5 4 0 4 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Season6 0 3.3 0 0 0 0 0 2.3 0 0 0 0 0 0 4 0 2 0 4 0
Sergei 4 4 4 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Season12 0 4 0 0 0 2 0 2.7 0 0 0 0 0 4 4 0 2 0 4 0
Season13 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 2 0 4 0
Munch 4 4 4 3.3 0.3 0 4 4 4 3.7 4 4 1.7 2 4 2 2 0 0 0
Minion 4 2 4 4 0 0 0 3.7 0 0 0 2 0 0 0 2 0 0 0 0
Mecon 0 0 0 0 3.7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2
Season24 4 0 4 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Morel 2.3 1 4 3 0 0 0 3 0 0 0 2 1.7 0 4 2 0 0 0 0
Season27A 0 4 0 0 0 2 0 3.7 0 0 0 0 0 0 4 0 2 2 4 0
Sw2 4 3.3 4 4 0 0 4 3 2 1.3 4 0 0 0 0 3.3 0 0.7 3 0
FelixO1 0 0 0 0 0 0 1 0 2 2 1.3 3 0 4 4 0 2 4 4 3.7






Phage Melville was found to have the broadest host range since it is capable of infecting 
85% (17/20) of strains tested and able to efficiently infect (defined here as a score >3, which 
corresponds to an EOP of ~0.05–0.5) 13 strains. Phage Mecon was found to have the narrowest 
host range by using this method, which capable of efficiently infecting only its own host and 
lysing one other strain. 
Phage Felix O1, a well-studied broad host range phage, was previously shown to lyse 
85.3% (191/224) of Salmonella strains and 5.9% of Escherichia coli strains when tested by a  
spot assay at a concentration 6 × 1010 PFU/mL [72]. In the present study, this phage was able to 
infect only 55% (11/20) Salmonella strains tested when applied at concentrations of ~105  
PFU/mL or less. This difference illustrates the importance of assay parameters in estimating the 
host ranges of phages since application of high phage titers can tend to overestimate bacterial 
sensitivity to phage [119]. Consistent with this observation, Welkos et al. (1974) further showed 
that spot testing Felix O1 at 1012 PFU/mL resulted in an increase of the apparent sensitivity of 
Salmonella strains to 98.5%. 
Defined as the highest dilution for the phage to produce countable plaques on its 
propagation host, the phage titer of the RTD in this study is slightly lower than the method 
described by Wilson and Artkinson [120] in which RTD was defined the lowest serial dilution 
for the phage to produce a confluent zone of lysis. By using both RTD and 100× RTD, this 
method was designed to test the ability of phages to replicate on a host strain without the false 
positive results due to abortive infection and lysis. Without that, it can be seen when high phage 






~2 log10 range [107,119]. The scoring system used in this study also helps in methodology 
comparison by providing a numerically consistent, semi-quantitative result. 
2. Determination of Microtiter Assay Parameters 
Based on the results of the spot host range assay, pilot experiments that explored the 
parameters for a liquid culture-based host range assay were performed. Phage-host combinations 
representing sensitive, intermediate, and resistant phenotypes were selected to evaluate the 
performance of different levels of bacterial and phage inocula in a 96-well microplate format 
assay (see Figure 10). 
Figure 10 A,D, which show the growth of the S. Anatum strain FC1033C3 in the 
presence of phage Sasha at low (~105 CFU/mL) and high (~108 CFU/mL) bacterial inoculum 
levels, represent the scenario of high bacterial sensitivity to phage with a score of 4 (EOP ~ 1) in 
the spot host range assay (see Figure 9). The initial bacterial inoculum level had an effect on the 
shape of the bacterial growth curve, but in both experiments, the phage was able to produce 
strong control of growth in liquid culture. The level of phage inoculum had only a minor effect 
on the bacterial growth phenotype. In the low-inoculum condition (see Figure 10A), phages were 
able to suppress bacterial growth up to approximately nine hours while in the high-inoculum 
condition (Figure 10D), inhibition of bacterial growth was not observed until 1–2 h of the 
experiment with OD550 reaching a minimum at five hours followed by bacterial regrowth at the 
end of the experiment. In the low inoculum condition, the input multiplicity of infection (MOI) is 
relatively high (~10–103 PFU:CFU). Therefore, the shape of the growth curve phage likely 
reflects an initial killing of most of the bacterial population followed by the regrowth of a phage-







Figure 10. Sample growth curves illustrating different phage sensitivity phenotypes in the low- 
and high-inoculum experimental setups. Reprinted from Xie et al., 2018 [96]. The X-axis 
indicates the OD550nm and the Y-axis represents the time in hours. Panels (A–C): experiments run 
with the low bacterial inoculum condition (~105 CFU/mL); panels (D–F): experiments run with 
the high bacterial inoculum condition (~108 CFU/mL). Both conditions were challenged with 
phage at 108 PFU/mL, 107 PFU/mL, and 106 PFU/mL; POS: positive culture control with no 
phage. Phage-host pairs were selected based on their scores from the spot host range assay, 
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inoculum condition is relatively low (~0.01–1 PFU:CFU), so significant lysis of the bacterial 
population cannot occur until the input phages have undergone multiple replication cycles to 
reach high enough concentrations to infect the majority of cells in the culture. When the bacterial 
host is highly sensitive to the phage, the low inoculum condition appears to mainly show the 
time until the arisal of a phage-resistant population while giving little information on factors such 
as the rate of phage replication. However, by using the high inoculum method, the phage must be 
able to replicate fast enough to outnumber, infect, and lyse a large proportion of the bacterial 
population in order to observe a significant reduction in OD550, which provides more information 
on phage virulence. 
A scenario of intermediate bacterial sensitivity to phage was evaluated using S. Newport 
strain USDA2 and phage Munch (spot assay score of 2, Figure 9). In the low bacterial inoculum 
condition (see Figure 10B), growth curves at phage concentrations of 107 and 108 PFU/mL were 
similar to those observed for the highly sensitive phage-host pair shown in Figure 10A. At the 
lowest phage concentration (106 PFU/mL, Figure 10B), the OD550 rose similar the positive 
control peaked at six hours and then dropped until the regrowth of the culture at ~10 h. In the 
high bacterial inoculum condition (see Figure 10E), the bacterial growth curve was qualitatively 
different from the sensitive phage-host pair (see Figure 10D), which produces a dose-dependent 
reduction in bacterial growth that was similar to the sensitive host at high phage concentration 
but weaker at the lower phage concentrations. This combination represents a situation in which 
the phage is able to infect its host, replicate, and produce progeny, but it may not be able to 






observation demonstrates that the high inoculum condition provides greater discriminatory 
power between intermediate phage sensitivity phenotypes. 
Phage Sasha and S. Typhimurium strain USDA1 (see Figure 10C and Figure 10F), which 
represents bacterial insensitivity to phage with a spot assay score of zero (see Figure 9), yielded 
no observable effects of phage on bacterial growth under any condition. This would be the result 
expected in the case of true phage resistance where the phage is unable to interact with the 
bacterium and has no effect on its growth.  
Based on the observations of bacterial growth inhibition in Figure 10, the high bacterial 
inoculum condition (~108 CFU/mL) with phage inoculation at 108 PFU/mL and 106 PFU/mL 
(corresponding to multiplicities of infection of ~1 and 0.01, respectively) were selected for 
conducting microtiter host range assays for the remainder of the phage collection. These 
parameters appeared to provide the greatest discriminatory power between high and intermediate 
phage sensitivity phenotypes, which was illustrated by the differences between Figure 10D and 
Figure 10E. The high bacterial inoculum condition demonstrated dosage effects of phage 
treatment with a higher observable effect on growth than was observed in the low inoculum 
condition. Phage concentrations of 108 PFU/mL and 106 PFU/mL were selected for further 
assays in order to simplify the method since the 107 PFU/mL condition did not appear to add any 
additional discriminatory power. 
3.  Measurement of Phage Host Range and Virulence by Microtiter Plate Assay 
Using the high inoculum condition and two phage concentrations as described above, the 
remaining 297 phage-host combinations were tested in a liquid culture-based host range assay in 






comparisons, each growth curve was transformed (as shown in Equation (2) and Figure 9) into a 
single value representing the difference under the growth curves between the phage treatment 
and the positive control (see Figure 11). Since the largest standard deviation observed in any 
individual assay was 10.89, an assay score of greater than 10.9 was used as a cutoff to 
distinguish a legitimate signal from noise. Using this simple cutoff, 186 individual assays 
produced a positive signal in this system. Similar to the results found in the spot host range assay 
(see Figure 9), phage Melville displayed the broadest host range capable of infecting 16/20 
(80%) of hosts tested (see Figure 11) with the highest score of 80 against S. Reading strain 330-1 
at a phage inoculum of 108 PFU/mL.  
A phage dosage effect was observed across this assay with greater bacterial growth 
suppression observed in the high phage concentration (108 PFU/mL) condition. As an example, 
phage Felix O1 was able to suppress bacterial growth in 25% (5/20) strains at a phage 
concentration 106 CFU/mL and the observed suppression expanded to 60% (12/20) of strains 
when the phage concentration was increased to 108 CFU/mL. The greatest difference in bacterial 
growth between the two tested phage concentrations was in the combination of phage Felix O1 
against S. Montevideo strain H1042-3 in which the low phage concentration produced a score of 
1 (bacterial growth almost identical to the no-phage control) and the high concentration produced 
a score of 71 (strong suppression of bacterial growth). Across all assays, the 106 PFU/mL phage 
inoculum produced 80 positive results (score >10.9) while the 108 PFU/mL inoculum produced 
106 positive results. The overall distribution of microtiter assay scores was statistically greater in 
the assays with higher phage concentration (Wilcoxon/Kruskal Wallis Test, p = 0.0141). This 







Figure 11. Host range of 15 Salmonella phages against 20 Salmonella strains is determined by 
the microtiter plate liquid assay at two initial phage concentrations of 106 PFU/mL and 108 
PFU/mL. Reprinted from Xie et al., 2018 [96]. Values indicate average liquid assay scores 
calculated by Equation (2) across three replicate experiments. To aid the reader, cells are shaded 
with stronger color intensity indicating a greater score. Assay score represents the differences in 
area under the bacterial growth curve with and without phage. Larger numbers indicate a greater 
suppression of bacterial growth in the presence of phage. Boxed cells indicate the initial isolation 
and propagation host of the phage. Standard deviations of each experimental unit across this 
assay ranged from 0.03 to 10.89. Negative values falling within one standard deviation were 
adjusted to zero for the convenience and for calculating the following comparison between two 
host range methods. 
108 62 53 60 62 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
106 55 48 48 55 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0
108 65 0 58 59 0 2 0 0 0 0 0 0 0 0 0 0 0 1 0 0
106 55 0 47 54 1 4 2 1 0 0 0 0 0 0 0 0 0 3 0 0
108 1 15 0 1 2 21 0 27 4 6 7 0 0 10 11 0 5 6 42 4
106 0 21 0 0 1 21 0 23 0 1 0 0 0 10 15 0 8 2 42 0
108 65 55 57 63 0 2 6 0 0 0 0 0 0 0 0 0 0 1 0 0
106 58 51 52 56 0 2 4 0 0 0 0 0 0 0 0 0 0 0 0 0
108 13 10 0 0 25 80 1 49 7 13 11 4 1 79 79 2 12 12 25 3
106 2 32 0 0 3 46 0 34 0 0 1 0 1 76 79 0 8 2 21 0
108 0 0 0 0 0 15 0 0 0 8 7 0 0 4 8 0 10 0 47 0
106 0 0 0 0 0 0 0 0 0 0 13 1 0 6 10 0 9 0 46 0
108 9 27 9 9 19 0 17 60 27 29 0 48 45 56 17 7 31 0 0 0
106 6 0 8 7 0 0 21 45 7 0 0 47 39 23 17 9 47 0 0 0
108 65 24 68 68 0 0 0 43 6 0 0 13 14 13 19 9 0 0 1 0
106 50 0 53 54 0 0 0 41 1 0 0 10 12 2 16 10 0 0 1 0
108 0 0 0 0 74 0 14 33 3 0 0 2 0 52 0 5 2 0 13 32
106 0 0 0 0 65 0 0 5 0 0 0 1 0 16 0 0 0 0 0 0
108 53 4 54 53 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1
106 47 1 49 47 0 0 0 0 0 0 0 1 0 0 0 1 0 2 0 2
108 20 26 5 9 0 0 0 34 0 1 0 6 7 5 7 0 0 0 0 0
106 34 1 9 10 0 0 0 35 0 1 0 7 8 1 10 5 0 1 0 0
108 0 23 0 0 3 14 0 22 3 12 8 0 0 9 9 2 11 2 32 3
106 0 31 0 0 0 14 3 19 0 2 0 0 0 11 14 1 3 2 28 0
108 77 86 77 78 0 2 21 21 0 13 27 0 4 0 0 21 8 35 19 0
106 73 79 68 72 1 0 21 22 0 15 21 0 1 0 0 21 0 0 21 0
108 0 0 0 0 10 19 65 6 4 28 18 66 71 38 24 7 27 70 64 73
106 0 0 0 0 2 0 29 2 0 2 4 3 1 17 4 0 1 59 23 72
108 30 0 26 27 44 0 34 39 2 57 70 38 32 79 51 80 75 70 43 0































































































































































































spot assay where the testing phage at higher titer resulted in an increased apparent sensitivity to 
phage in Salmonella. This observation highlights the importance of the assay parameters on the 
observed phenotypes and the value of using multiple initial phage concentrations to ascertain 
phage host range and virulence in such assays. 
An advantage of liquid culture assays over the traditional spot assay is that they measure 
the ability of a phage to control bacterial growth over time, which is a property typically referred 
to as phage virulence [136]. Measurement of virulence in this sense is an integrated result of a 
phage’s ability to infect, reproduce within, and lyse a bacterial host. Phages with high adsorption 
rate constants, short latent periods, and large burst sizes would be expected to produce a stronger 
signal in this type of experiment [137],[138]. In the case of the microtiter assay, multiple 
comparisons between phage-host pairs can be made because of the standardization of the assay 
and the mathematical transformation of the resulting bacterial growth curves into single 
numerical values. This assay can, therefore, determine the ability of a phage to interact with a 
bacterial strain at a detectable level (the phage “host range”) and also measure the ability of a 
phage to control a bacterial population in a liquid culture (phage “virulence”). 
4. Comparison Between Two Host Range Methods 
The differences between the two host range methods are shown in Figure 12, which was 
calculated by Equation (3). Difference scores close to zero of either sign indicate high agreement 
between the two methods and greater deviations from zero indicate greater disagreement. 
Negative values (blue) indicate a greater response was observed in the microtiter plate assay 








Figure 12. Agreement levels between two host range methods. Reprinted from Xie et al., 2018 
[96]. Equation (3) was used to determine agreement levels between two host range methods. One 
spot assay score representing one bacteria-phage combination (see Figure 9) was compared to 
two liquid assay scores at two different phage concentrations (see Figure 11) to determine if one 
phage concentration in the liquid assay yielded a difference in agreement levels. Values closer to 
zero indicate greater agreement between the two methods and values closer to 100 indicate 
disagreement. Negative values indicate greater bacterial sensitivity to phages observed in the 
liquid assay and positive values indicate greater sensitivity observed in the spot assay. Color 
intensity indicates greater divergence from zero in either direction, with blue shades indicating 
negative values and red shades indicating positive values. Boxed cells indicate the initial 
isolation and propagation host of the phage. 
108 -17 0 -13 -17 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
106 -15 0 0 -15 0 0 0 0 0 0 0 0 0 0 0 0 0 -2 0 0
108 -12 0 0 -2 0 -3 0 0 0 0 0 0 0 0 0 0 0 -2 0 0
106 -17 0 0 -15 -2 -9 -4 -2 0 0 0 0 0 0 0 0 0 -6 0 0
108 -2 47 0 -2 -5 -50 0 -2 -10 -14 -17 0 0 -24 74 0 38 -14 0 -10
106 0 33 0 0 -2 -50 0 8 0 -2 0 0 0 -24 64 0 41 -5 0 0
108 -18 0 -4 -15 0 -4 -11 0 0 0 0 0 0 0 0 0 0 -2 0 0
106 -14 0 -2 -10 0 -4 -8 0 0 0 0 0 0 0 0 0 0 0 0 0
108 -16 87 0 0 -32 -51 -1 5 -9 -16 -14 -5 -1 0 0 -3 35 -15 68 -4
106 -3 58 0 0 -4 -11 0 23 0 0 -1 0 -1 0 -4 0 41 -3 72 0
108 0 0 0 0 0 -32 0 0 0 -17 -15 0 0 -9 58 0 29 0 0 0
106 0 0 0 0 0 0 0 0 0 0 -28 -2 0 -13 53 0 30 0 0 0
108 81 44 81 64 -32 0 80 -25 44 32 100 0 -51 -67 80 42 -15 0 0 0
106 87 100 83 68 8 0 55 4 85 93 100 0 -40 1 80 31 -50 0 0 0
108 4 15 0 0 0 0 0 29 -9 0 0 31 -21 -19 -28 37 0 0 -1 0
106 7 50 2 0 0 0 0 17 -2 0 0 31 -22 -4 -30 31 0 0 -2 0
108 0 0 0 0 0 0 -19 -45 -4 0 0 -3 0 -61 0 -7 -3 0 -18 11
106 0 0 0 0 0 0 0 -8 0 0 0 -2 0 -25 0 0 0 0 0 54
108 0 -8 -2 -25 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -2
106 0 -2 -4 -25 0 0 0 0 0 0 0 -2 0 0 0 -2 0 -4 0 -4
108 -139 -256 78 0 0 0 0 -278 0 -11 0 0 -21 -56 56 67 0 0 0 0
106 -257 23 43 0 0 0 0 -250 0 -10 0 -3 -23 -10 33 17 0 -10 0 0
108 0 0 0 0 -13 -11 0 -3 -13 -52 -35 0 0 -39 61 -9 2 41 -39 -13
106 0 0 0 0 0 5 -10 31 0 -6 0 0 0 -35 55 -3 40 44 10 0
108 32 0 32 31 0 -2 97 66 61 30 90 0 -5 0 0 76 -9 -23 69 0
106 29 0 21 30 -1 0 95 63 61 20 95 0 -1 0 0 73 0 18 64 0
108 0 0 0 0 -16 -30 -77 -9 44 6 4 -28 -111 41 63 -11 8 -9 0 -21
106 0 0 0 0 -9 0 -101 -9 50 41 15 62 -4 81 83 0 46 -157 0 -220
108 40 0 42 33 19 0 61 51 47 -22 4 52 59 0 40 -76 5 -6 21 0


























































































































































































































Among these 600 points of comparison (fifteen phages against twenty bacterial strains at 
two concentrations), the majority of the assay results (74%, 444/600) showed high agreement in 
which their difference scores ranged between an arbitrary limit of −20 to +20 while only 4.7% 
(28/600) showed high disagreement with difference scores of +/−80 or more. Among 300 phage-
host combinations, over half (171/300, or 57%) of the total results were cases where both 
methods produced a result of phage insensitivity (score of 0 in the spot assay and less than 10.9 
in the microtiter assay), which indicates that the two methods tend to support each other in 
answering the question of whether a bacterial strain is sensitive or insensitive to a given phage.  
In 19 phage-host combinations, the spot assay indicated phage insensitivity (score = 0) 
but the microtiter assay produced a detectable response (score > 10.9). At the same time, 19 
other phage-host combinations showed no response (score < 10.9) in the microtiter assay but a 
detectable response (score > 0) in the spot assay. This supports the finding that both methods are 
generally equally likely to detect phage sensitivity across phage-host pairs, but any given phage-
host pair could show a false-negative result (compared to the other method) approximately 6% of 
the time in either assay. Differences in detecting phage sensitivity between the two methods were 
not evenly distributed across phage-host pairs. In the spot assay, 16/19 (84%) of false-negative 
results (where the spot assay score was 0 but the microtiter assay score was >10.9) were confined 
to the results of five phage isolates. In the microtiter assay, 11/19 (58%) of false-negative results 
(where the microtiter assay score was less than 10.9 but the spot assay score was >0) were 
confined to only two phages. This indicates certain phage isolates may fail to provide a response 
in either method but this can only be determined empirically. For example, phage Munch was 






this was modulating bacterial growth in the microtiter assay in 11/20 strains at the 108 PFU/mL 
inoculum and in 7/20 strains at the lower 106 PFU/mL inoculum (see Figure 12). While the lack 
of signal does not definitively rule out the ability of a phage to interact with the test strain, it does 
indicate that the phage cannot efficiently infect and lyse the strain, which is a primary concern 
when selecting phages for potential use in therapeutic applications. 
When disagreements arose between the two methods, the spot assay tended to indicate 
higher levels of phage sensitivity. Of the 156 difference scores greater than 20 or less than −20 
(see Figure 12), 108 (69%) were positive, which shows a greater response in the spot assay than 
in the microplate assay. In the level of high disagreement (difference scores greater than ±80), 19 
out of 28 difference scores (68%) were positive, which shows that the ability of a phage to form 
plaques or clear zones on agar plates does not always confer the ability to suppress bacterial 
growth in liquid culture. For example, phage Munch, which showed high efficiency of plating 
against four S. Anatum strains in the spot assay with scores of 3.3 to 4 (see Figure 9), largely 
failed to inhibit bacterial growth of those strains in the microtiter assay (see Figure 11). The 
disagreement between the two methods also appeared to be associated with broad host-range 
phages and with slightly more than half (87/156) of all disagreement scores ≥ ±20 associated 
with only four phages: Munch, Sw2, FelixO1, and Melville. 
The ability of a phage to suppress bacterial growth in liquid culture is largely due to the 
integrated result of its adsorption rate, latent period, and burst size, which may be modulated by 
the physiological state of the host culture. Plaque formation is an analogous but not identical 
process. The spatial structure imposed by the soft agar overlay and its effects on phage diffusion 






[123,139]. Phages with lower adsorption rates can actually produce more robust plaques, which 
is observed in the case of coliphage lambda PaPa and produces larger and more visible plaques 
due to the loss of its side tail fibers [140]. 
Strongly negative difference scores (i.e., less than ~−100) tended to be produced when a 
phage was more effective against a test strain than on its own host in the microtiter assay since 
all scores were normalized to the result on their propagation host. This result produces an over-
unity microtiter assay score that can exceed even the highest possible score from the spot assay, 
which turns into a strongly negative difference score. In the case of most intermediate negative 
difference scores (i.e., from −20 to ~−100), the phage produced only a weak signal in the spot 
assay but was able to strongly control bacterial growth in the microplate assay. Hyman and 
Abedon [107] suggested that liquid culture-based host range methods can be used to determine 
the host ranges of phages with poor ability to form plaques on solid media. Phages with poor 
diffusion through soft agar overlays, very high adsorption rates, or long latent periods would be 
expected to produce smaller plaques with a potential impact on plaque-based measurements of 
phage sensitivity [123].  
 
Conclusion 
The majority of host range results produced by two methods agreed with one another, and 
the microtiter host range assay was generally able to determine phage host range at the same 
level of sensitivity as the conventional agar overlay spot method. This result indicated that the 
microtiter plate method developed here could serve as an alternative to the conventional agar 






range in the liquid culture-based microtiter assay provides several advantages over the traditional 
spot assay: it is repeatable, it eliminates the need for (often subjective) visual inspection of 
plaques, and provides information on both phage host range and phage virulence in a single 
assay. If desired, the large amounts of data generated by this method may be transformed into a 
single numerical value for inter-assay comparisons. Dosage effects were observed across the 
panel of phage-host combinations in the microtiter assay, in which testing phages at higher titers 
resulted in an increased apparent bacterial sensitivity to phage. This observation demonstrates 
the importance of assay parameters on the observed phenotypes. Conducting such assays with at 











CHARACTERIZATION OF SALMONELLA BACTERIOPHAGES AND APPLICATION TO 
REDUCE SALMONELLA ON CATTLE HIDE AND IN SOIL FROM CATTLE FEEDLOTS 
 
Introduction 
 In the United States, foodborne illnesses caused by Salmonella are estimated to number 
more than 1.2 million each year in the United States, with more than 23,000 hospitalizations and 
450 deaths [13]. The United States Department of Agriculture (USDA) Economic Research 
Service (ERS) indicates that Salmonella imposes the greatest cost among 14 major foodborne 
pathogens investigated in the United States, with an estimated annual economic cost of $3.4 
billion caused by Salmonella illness [21,22]. Salmonella is associated with a wide range of food 
commodities and beef was identified as a transmission vehicle in 5% (96/1,965) of Salmonella 
outbreaks during 1973 – 2011, in which ground beef contributed to 23% of beef-related 
Salmonella outbreaks [141]. Previous study indicated that commercial ground beef in the United 
States is contaminated with Salmonella at 4.2% [29]. While applying antimicrobial interventions, 
such as sodium hydroxide, sodium sulfide, chlorine, lactic acid and acetic acid, have been 
reported to reduce Salmonella prevalence on beef carcasses from 50.2% to 0.8%, there is little 
effect on ground beef made from edible beef trimmings [30,31]. Lymph nodes, which commonly 
present in lean trimmings destined for ground beef productions, could harbor Salmonella in cattle 
without displaying clinical symptoms of illness [32]. This finding implies that asymptomatic 






Two major theories of Salmonella colonization of lymph nodes have been proposed in 
previous studies: 1) Salmonella is transmitted to lymph nodes via cattle intake of contaminated 
water or feeds and 2) transdermal transmission in which Salmonella is introduced via insect bites 
or skin abrasions occurs. Pullinger et al. demonstrated the possibility of translocation of 
Salmonella from the distal ileum through lymphatics via type III secretion 1 (T3SS-1) [142]. 
This hypothesis was later tested in a Salmonella oral challenge study by Brown et al. [38], in 
which calves were orally inoculated either with a single high dose (~1010 CFU) of S. Montevideo 
or daily low dose (average 7.1x104) during a fourteen-day experiment. Peripheral lymph nodes 
collected and examined for Salmonella prevalence at the end of this experiment showed both 
single high dose and subsequent low dose inoculation resulted in colonization of peripheral 
lymph nodes of calves at harvest, with greater percentage of Salmonella positive lymph nodes 
(62.5%)  observed compared to daily low dose (12.5%) [38]. This same team conducted research 
on the hypothesis of transdermal Salmonella transmission via two challenge models. In the first 
study, S. Senftenberg was inoculated to calves intra- and/or trans-dermally by applying a skin-
allergy instrument over various ventral regions of skin, resulting in the predictable recovery of 
Salmonella from draining of region specific lymph nodes [36]. The Salmonella positive result 
was persistent for eight days post challenge in this study [36]. The following experiment 
assessed the concept of transdermal transmission by challenging cattle with horn flies that were 
previously fed with a blood meal containing S. Senftenberg [37]. The result showed that 8% 
lymph nodes were Salmonella positive after 5-day exposure, whereas 50% were positive from 
11-day exposure. This study implied that prolonged exposure to Salmonella containing flies has 






Although theories of Salmonella transmission and colonization of lymph node have not 
been conducted in combination systematically, exposure to Salmonella within beef cattle feedlot 
environment throughout the feeding operation seems to serve as the origin despite the various 
transmission routes. Researchers explored the impact of feedlot environmental Salmonella 
prevalence on transmission during different feed stages [39]. In this study, calves at weaning 
stage (stage 1) were separated at two feedlots, one with positive and one with negative 
Salmonella prevalence historically [40,41].  Calves were harvested at the end of stage 2 
(stocker), 3 (60 days on feed) and 4 (120 days on feed), and lymph nodes were collected for the 
examination of Salmonella prevalence. Results from this study indicated that prevalence of 
lymph nodes of cattle fed in Salmonella-positive feedlot increased as cattle moved into later 
stages of feeding, at 22%, 78% and 94.4% for feeding stages 2, 3 and 4, respectively, while cattle 
fed in the Salmonella-negative feedlot remained negative during all feeding stage. With negative 
Salmonella prevalence in lymph nodes of cattle from both treatment groups at stage 1, this result 
implied that environmental Salmonella prevalence during feeding operation has influences on 
prevalence of Salmonella in lymph nodes of cattle at harvest [39].  
Bacteriophages (phage) are viruses that infect bacteria, and are the most abundant form of 
life on earth, estimated to number some 1031 to 1032 organisms in total [48,49]. Phages are 
ubiquitous in natural environment as well as in plants and animals as a part of their normal flora. 
Feeding environments of both beef and dairy cattle were previously identified as reservoirs of 
Salmonella phages [41,90,143]. A study on the prevalence of Salmonella and Salmonella phages 
in beef cattle feedlots indicated that more than 90% of soil and fecal samples harbor at least 






reservoirs of phage among four environmental sample type (soil, feces, feed and water) [41]. 
Phage isolated from these feedlot environmental samples displayed a diverse host range 
phenotypes, with phages ranging from infecting 10% to 85% of the tested Salmonella strains 
[96]. Switt et al. conducted a research study on genomic characterization of 22 Salmonella phage 
isolated in dairy farms and were able to identify a high level of genomic diversity among phages 
sequenced [144]. Phages characterized in this study belong to genus including  Viunalikevirus, 
Felixounalikevirus, Sp03unalikevirus, Chilikevirus and Jk06likevirus as well as a new viral 
genera Sp062likevirus that has been proposed to the International Committee on Taxonomy of 
Viruses (ICTV) [144].  
Phages are non-pathogenic to humans and are normal residents of the human microbiome 
[48,49]. The increasing spread of bacterial resistance to antibiotic has become a worldwide 
threat, resulting the renewal of interest in exploring bacteriophage as a potential alternative to 
control pathogenic bacteria in Western countries [58].  
The U.S. Department of Agriculture (USDA), Food and Drug Adminstration (FDA) and 
Environmental Protection Agency (EPA) have approved phage-based commercial products that 
are now available as antimicrobial interventions in food production. In the category of post-
harvest interventions, EcoShieldTM, a bacteriophage preparation produced by Intralytix Inc., 
obtained regulatory approval from the FDA through a “Food Contact Notification” (FCN No. 
1018) for use on raw meat cuts and trim to control E. coli O157:H7 prior to grinding [61]. 
SalmoFreshTM  from the same company gained approval with generally recognized as safe 
(GRAS) for application on poultry products for reducing Salmonella enterica population (GRN 






PhageGuard ListexTM and PhageGuard STM, which has been approved GRAS and certified to be 
used in organic production. Similar to ListShieldTM, PhageGuard ListexTM is used as a 
processing aid for control of L. monocytogenes. According to Microes, PhageGuard STM is 
intended to be used as a spray on food post harvested at points of contamination during 
processing and is expected to achieve 1.0 – 3.0 log10 reduction of Salmonellae. The pre-harvest 
intervention, Finalyse®, produced by Passport Food Safety Solutions, Inc., was approved for 
application on the hides of beef cattle to reduce E. coli O157:H7 prior to slaughter [59]. This 
product was recommended to be applied via a misting system in which cattle walk through the 
spraying system targeting full coverage of the animal before harvest. In the environmental 
biocontrol aspect, AgriPhageTM, a phage cocktail produced by Phagelux Inc. (previously 
OmniLytics Inc.), gained approval from the Environmental Protection Agency for application on 
growing produce in the field to reduce plant pathogenic bacteria [57].  
Previous antimicrobial efficacy studies on Salmonella phages demonstrate their capacity 
in reducing Salmonella population in poultry production. Described by Atterbury et al., oral 
administration of phages were able to significantly reduce Salmonella colonization, with the one 
selected phage reducing cecal colonization by ≥ 4.2 log10 CFU and the other by ≥ 2.2 log10 CFU 
within 24 h [129]. Other research studied the ability of phages to reduce Salmonella on chicken 
skin at 109 PFU/mL for 30 min in comparison with chemical decontamination agents (200 mg/L 
sodium dichloroisocyanurate for 10 min; 100 mg/L peracetic acid for 10 min and 2% (v/v) lactic 
acid for 90s), resulting in similar reductions of about 1 log10 CFU/cm2 observed [145]. A study 
conducted by Grant et al. evaluated the antimicrobial efficacy of a commercial available product, 






ground chicken associated Salmonella isolates showed reductions of 0.4 Log10 CFU/cm2 and 0.7 
Log10 CFU/cm2 reductions after 30 min and 8 h, respectively (P < 0.05) [146]. A previous 
National Pork Board funded research on the effectiveness of oral phage treatment in preventing 
Salmonella infection in pigs and/or reduce Salmonella population in infected pigs showed that 
the administration of 1010 phage Felix O1 were able to significantly reduce Salmonella in cecum 
by 1.59 log10 PFU per sample [147]. Antimicrobial efficacies of Salmonella phages were also 
explored in the seafood category, in which Galarce et al. observed a significant reduction in raw 
salmon samples on days 3, 6 and 10 incubated at 18°C (from 0.75 to 3.19 log10 CFU/g) and at 
4°C (from 2.82 to 3.12 log10 CFU/g) [148]. In the same study, phage treatment showed a lower 
reduction in smoked salmon (from 1.02 to 1.96 log10 CFU/g at 18°C and from 0.50 to 1.16 log10 
CFU/g at 4°C) [148]. A post-harvest application of phages as antimicrobial strategy were also 
conducted in raw beef, in which a significant reduction of 2–3 log10 cm−2 at 5 °C and >5.9 log10 
cm−2 at 24 °C were achieved [149].  
Phages are capable of targeting bacterial hosts with high specificity by recognizing 
unique bacterial surface structures, leaving the remaining microbiota unharmed. The high level 
of specificity makes phage treatment more favorable over other broad-spectrum antimicrobials 
that could cause collateral damage to the microbial flora [59]. Suggested by Garcia et al. [57] , 
phages can be applied to all stage of food production from “farm to fork” to prevent foodborne 
infections [59]. In the current study, we performed characterization of four lytic Salmonella 
phages with distinct genotypes, including their morphologies, infection kinetics, and genomic 
analysis. In addition to their basic characteristics, we also examined their cross-resistance in 






conducted efficacy studies on their antimicrobial capacities using two models, a cattle hide 
model and a soil model, in order to reduce the transmission of Salmonella from the beef cattle 
feedlot environment to the final product, with intention of improving the microbiological safety 
of ground beef. 
 
Materials and Methods 
1. Bacterial Strains and Culture Conditions 
S. Anatum strain FC1033C3 was isolated previously in fecal samples from a cattle feedlot 
located in south Texas [41]. S. Montevideo strain USDA3 and S. Newport USDA2 were obtained 
from T. Edrington (USDA, College Station, TX). A nalidixic acid-resistant S. Anatum strain, 
which was used in efficacy testing models of phages, was obtained by plating an overnight 
culture of S. Anatum strain FC1033C3 on tryptic soy agar (TSA) (TSB plus 1.5% w/v Bacto agar 
(Becton-Dickinson)) supplemented with 25 mg/l nalidixic acid, incubating at 37 ºC overnight 
and selecting for surviving colonies. Bacteria and phages were enumerated in tryptic soy broth 
(TSB) (Becton-Dickinson) or tryptic soy agar (TSB plus 1.5% w/v Bacto agar (Becton-
Dickinson)) aerobically at 37 ºC.  
2. Bacteriophage Strains and Culture Conditions 
Isolation of phage Sergei, Season12 Munch and Sw2 was described in a previous study 
[96]. High-titer phage stocks were prepared by the confluent plate lysate method [135]. Phage 
stocks were diluted in phage buffer (100 mM NaCl, 25 mM Tris-HCl pH 7.4, 8 mM MgSO4, 






stocks were adjusted in phage buffer to achieve concentrations of 108 and 109 PFU/mL before 
use in the hide and soil models.  
3. Transmission Electron Microscopy Imaging 
Transmission electron microscopy of phages were performed by staining virions with 2% 
uranyl acetate and imaging in a JEOL 1200 EX transmission microscope operating at an 
acceleration voltage of 100 kV as previously described [150,151]. Head dimensions and tail 
length were measured using ImageJ [152,153] and standardized against images of a carbon 
grating replica of known dimensions (Ted Pella, cat# 607). Virion head width was measured face 
to face perpendicular to the axis of the tail, and head height was measured from vertex to vertex 
from the top of the tail to the top of the head. 
4. Genomic DNA Extraction, Sequencing and Bioinformatic Analysis 
Phage genomic DNA was prepared by using a modified Wizard® DNA Clean-Up 
System (Promega, Madison, WI) [151,154]. Genomic DNA were stored at 4 ºC before use.  
Bacteriophage genomic DNA was sequenced as paired-end 250 bp reads using the 
Illumina MiSeq platform. FastQC (bioinformatics.babraham.ac.uk), FastX Toolkit 
(hannonlab.cshl.edu), and SPAdes 3.5.0 [155] were used for read quality control, read trimming, 
and read assembly, respectively. Genome closure were achieved using PCR and Sanger 
sequencing of the products. Glimmer3 [156] and MetaGeneAnnotator [157] were used to predict 
protein coding genes and manually corrected, while tRNA genes were predicted using 
ARAGORN [158]. Putative protein functions were assigned based on sequence homology 
detected by BLASTp [159] and conserved domains detected by InterProScan 5 [160]. Analyses 






5. Growth Kinetics  
Determination of adsorption rate were performed as previously described [135]. A mid-
log culture of S. Anatum strain FC1033C3 (OD550  ~ 0.25) was infected with phage at a 
multiplicity of infection (MOI) of ~0.01 and incubated at 37 ºC statically. Aliquots were taken 
periodically and diluted 100X in phage buffer to stop adsorption. Diluted aliquots were 
centrifuged at 18,000 g for 5 min and the supernatants that contained unadsorbed phages were 
titered. The values of log percent free phage at each time point were plotted against time, and the 
slopes were obtained from a linear regression line generated in Microsoft Excel. The adsorption 
rate constant K for each phage was calculated as (-slope)/(bacterial concentration) [135]. Three 
biological replications were performed for each phage. 
One-step growth experiments were performed using a modified method of Adams [135]. 
A mid log culture of S. Anatum strain FC1033C3 (OD550 ~ 0.5) was combined with phage at 
MOI ~0.01 and allowed adsorption for 10 min, followed by 100X dilution in phage buffer and 
centrifugation at 18,000 g for 5 min. Supernatants containing unadsorbed phages were removed. 
Pellets containing phage-infected cells were resuspended in TSB and incubated at 37 ºC. 
Aliquots were taken periodically and immediately titered by the soft agar overlay method [135]. 
The phage latent period was defined as the mid-point of the rise period between the end of the 
initial adsorption period and lysis [163]. Phage burst size was calculated as the average yield of 
PFU per infected host cell [135]. Three biological replicates were performed for each phage. 
6. Characterization of Cross Resistance of Phages 
Phage-resistant mutants of S. Anatum FC1033C3 were selected by co-culturing the 






TSA plate. Efficiency of plating (EOP) of the remaining phages was performed against each 
phage-resistant strain to determine if resistance to one of the test phages conferred resistance to 
other phages in the collection [96]. Two phages with independent resistance were combined and 
evaluated for their efficacy of suppressing S. Anatum in vitro assay.  
Briefly, a standardized inoculum (~105 CFU/mL) obtained by adjusting fresh overnight 
cultures OD550nm ~0.5 and diluting 1000-fold in TSB was placed in 96-well microtiter plates and 
challenged separately with single phages or phage mixtures at concentrations of 108 and 106 
PFU/mL. The plates were incubated at 37 °C with double orbital shaking in a Tecan Spark 10 M 
plate reader (Tecan Group Ltd., Männedorf, Switzerland) and growth was monitored by 
measuring OD550nm at 30-min intervals for 12 h. Growth curves were achieved by plotting OD 
after baseline adjustment against time. Three biological replicates were performed in this assay.  
7. Efficacies of Phages on Reducing Salmonella Population in Two Testing Models 
Previous work has shown that the feedlot environment and cattle hide are major 
reservoirs of Salmonella that could subsequently contribute to the colonization of lymph nodes 
of cattle [33,41].Two testing models, cattle hide model and soil model, were used in the current 
study for efficacy testing of the antimicrobial capacities of phages. Mentioned in multiple 
previous studies, S. Anatum was the most frequently found sevovar in cattle feeding environment 
and therefore, was selected in this study as the model bacterial strain.  
Phage Sergei, Season12, Munch and Sw2, representing four distinct genotypes, were 
used against the model strain in efficacy studies in two models mentioned above. In addition, 
two phage combinations, Sergei and Mucnch as well as Sergei and Sw2, were also selected for 






7.1 Cattle Hide Model 
Overnight culture of nalidixic acid marked S. Anatum strain FC1033C3 was centrifuged, 
washed three times with peptone water and inoculated into a sterile gelatin-based slurry to mimic 
the adherent properties of soil and fecal contamination [164]. Cattle hide pieces were obtained 
from Texas A&M Rosenthal Meat Science and Technology Center during harvest with a circular 
punch to achieve an average surface size of 70 cm2. The slurry was then applied to freshly-
collected cattle hide pieces and allowed 30 min of contact time, followed by removal of excess 
material.  Inoculated hide pieces were then sprayed with 5 ml of individual phages and phage 
combination at concentrations of 108 or 109 PFU/ml and held at 37 °C for one hour. Sham 
treatments were performed by spraying 5 ml of peptone water onto inoculated hide pieces and 
held at 37 °C for one hour. Treated hide pieces were placed in filtered stomacher bags with 100 
ml of peptone water and homogenized in stomachers for 60 seconds. Homogenized mixtures 
were centrifuged at 8,000 x g for 10 min and pellets were suspended in peptone water, serially 
diluted and spread on xylose lysine deoxycholate agar (XLD) supplemented with 25 mg/l 
nalidixic acid and 0.1% cycloheximide. Plates were incubated at 37 °C for 18 hours and plate 
counts were performed. 
7.2 Soil Model 
The bacterial inoculum was prepared as described above. Soil were collected in a cattle 
feedlot located in College Station, TX. Soil was sterilized by autoclaving at 121 °C for 30 
minutes for three times, and 10 g aliquot of sterilized soil was placed into a standard 90 mm 
petri-dish. Inoculation of soil was achieved by spraying 3mL of inoculum on the soil aliquot in 






sprayed with 3 mL of individual phages and phage combinations at concentrations of 108 or 109 
PFU/ml and held at 37 °C for 1 hour or 24 hour treatment periods. Treated soil samples were 
placed in filtered stomacher bags with 100 ml of peptone water and homogenized in stomachers 
for 60 seconds. Homogenized mixtures were centifuged at 8,000 x g for  10 min and pellets were 
suspended in peptone water, serially diluted and spread on xylose lysine deoxycholate agar 
(XLD) supplemented with 25 mg/l nalidixic acid and 0.1% cycloheximide. Plates were incubated 
at 37 °C for 18 hours and phage plaque counts were performed. 
In order to understand the dynamic of reduced efficacies of phage treatments observed in 
the soil model, a standard sand (MilliporeSigma, Burlington, MA) model was performed on one 
selected phage, Sw2, with the same experimental method. This additional experiment in sand 
was intended to provide an inert condition to study the interaction between bacteria and phage in 
a fine particle matrix with high total surface area that mimics the physical property of soil.  
8. Statistical Analysis 
Bacterial survival from different phage treatments in two testing models were analyzed 
for differences between treatments by one-way analysis of variance (ANOVA) at α = 0.05 via 
JMP v12.1.0 (JMP® Statistical Discovery™ From SAS, Cary, NC). Significantly differing 
bacterial concentrations were separated by Student's t-test (P < 0.05). 
 
Results 
1. Bacteriophage Morphology  
 Images of four phages via TEM are shown in Figure 13. Phages Sergei, Season12 and 







Figure 13. TEM images of four phages. TEM of phages were performed by staining the virions 
with 2% uranyl acetate and imaging in a JEOL 1200 EX transmission microscope operating at an 
acceleration voltage of 100 kV  as previously described [150,151]. Black lines indicate 100 nm. 



















to be a Myoviridae with a contractile tail. Morphologically, phage Sergei has an icosahedral head 
of 64.4 nm in diameter and a tail of 156.2 x 10.6 nm in size; phage Season12 has an icosahedral 
head of 52.9 nm in diameter and a tail of 231.1 x 11.8 nm in size; phage Munch has a slightly 
elongated head with 118.8 nm in length and 98.5 nm in width, alone with a tail of 125.3 x 23.2 
nm in size; phage Sw2 has an icosahedral head of 79.5 nm  in diameter and a tail of 185.2 x 8.3 
nm in size.  
2. Genomic Analysis 
Genome maps of Season12, Munch and Sw2 are shown in Figure 14A. 14B and 14C, 
respectively. Genome map of Sergei presented by Zeng et al. [165].  
Phage Sergei belongs to a group of closely related phages that was proposed to be 
grouped as a new virus genus 9NAlikeviruse by Zeng et al. [165]. Genomic characteristics of this 
phage include a genome size of 56,051 bp with a GC-ratio of 43.5%. The assembly of this phage 
runs into a single circular contig, implying direct termini contained in the virion genome [165]. 
Annotation predicts 91 protein coding genes in Sergei, in which (59/91) 64.8% are hypothetical 
proteins with no assignable function. No tRNA genes were found in the genome of Sergei [165].  
Phage Season12 is closely related to phage Chi (KM458633) the type phage in the genus 
of Chilikevirus [89]. The genome of Season12 is 59,059 bp in length with a GC content of 
56.5%. The assembly of this genome was a single linear contig. At the left (5’) end of the 
chromosome of phage Season 12, it has 12-bp predicted 5’-overhanging cohesive (cos) ends with 
the sequence 5’-GGTGCGCAGAGC that is conserved with phage Chi and other Chi-like phages 
[89,166]. There are 76 protein coding genes predicted in the genome of Season12, in which 50 






1 kb tandem repeats were identified from 33834 – 36947 bp located downstream of the tail fiber 
protein.  
Phage Munch is a so-called “jumbo” phage with a large genome size of 350,103 bp and a 
relatively low GC content of 35.6%. Its genome has 532 predicted protein coding genes and 22 
tRNA sequences. Of these predicted protein coding sequences, only 118 were given a putative 
function. Munch is a relatively novel phage with 159 predicted coding sequences that share no 
homology to any sequence in the NCBI database. In the genome of Munch, three region 
containing repeated sequences were found via tool Dotmatcher on CPT Galaxy bioinformatic 
platform (Figure 15) [161]. Protein sequences from these three region were further compared 
using BLASTp [159]. Genes from the first repeat region located in the first 20 kb of the genome 
did not display detectable similarity in protein sequences, suggesting that if these proteins are the 
result of gene duplication, this event would have occurred in the distant past. The second repeat 
region was located within the tail fiber protein gene (see Figure 14B), although tandem repeats 
was detected in DNA sequencing level, there is no obvious protein repeated motif identified in 
the gene product. Interestingly, the last repeat region with spend the right most 20 kb of the 
genome contains 13 tandem repeats of a gene encoding a predicted DNA condensation protein. 
A 21296bp of direct terminal repeat were identified via tool PhageTerm [167]. The most related 
phage to Munch found in the database is phage 121Q (KM507819.1) that is 55.1% identical in 
DNA sequence according to Emboss Stretcher [168].  
Phage Sw2 is closely related to the well-studied lytic Siphoviridae, T5 [81]. Phage Sw2 
has a genome of 114,274 bp in size with a GC-ratio of 40.2%. A 8123 bp-long terminal repeat 






Figure 14. Genome maps of Season12, Munch and Sw2.  Genome maps of Season12, Munch and Sw2were shown in figure 14A, 14B 
and 14C, respectively. Maps of phage genomes were obtained by the tool Genome Mapper via CPT Galaxy [161] and WebApollo 























protein coding genes, in which 82 were given a putative function. There are 29 tRNA sequences 
annotated in the genome of Sw2.  
3. Growth Kinetics  
 Adsorption rate, latent period and burst size were obtained by protocols described in 
Materials and Methods and result of these growth kinetic parameters are summarized in Table 4. 
The greatest standard deviation of the phage absorption rates observed is 9.58x10-10 and the R2 of 
the regression line obtained to calculate the slope needed for the calculation for K ranged from  











4. Characterization of Phage-Resistant Mutations 
 The efficiency of plating (EOP) obtained by testing each of four phages against the wild 
type S. Anatum FC1033C3 and four phage-resistant mutations of tested strains were shown in 









Sergei 1.47 x 10-9 46 48
Season12 2.71 x 10-9 52 39
Munch 4.70 x 10-9 63 16







Figure 15. DNA Dot plot obtained by mapping genomic sequence of Munch. Result obtained by 
plotting the genomic sequencing or Munch again itself via tool dotmatcher on CPT Galaxy 











and the EOP of phages tested against phage-resistant mutants are shown as the ratio of EOP 
against wild type. According to the results shown in Table 5, two different types of phage 
resistant independences are observed. Phage Sergei and Munch were able to infect the phage 
resistant mutants of each other with EOPs close to 1, implying that Sergei and Season12 are 
genetically independent for phage resistance. In contrast, phage Munch was able infect the 
Season12-resistant mutant while phage Season12 was unable infect the Munch-resistant mutant, 
implying that Season12 and Munch are only partially independent for this phenotype. 
5. Efficacy Testing on Single and Mixed Phages Against S. Anatum FC 1033C3 in a 
Microtiter Plate Liquid Assay 
 With the observation from Table 5, using the combination of two phages that are fully 
independent for phage resistance was hypothesized to be capable of improving antimicrobial 
efficacy in a microtiter plate liquid assay compared to testing single phages against the wild type 
strain. In contrast, using a combination of phages that are partially independent was hypothesized 
to be incapable of improving antimicrobial efficacy compared to using single phages. To test this 
hypothesis, two phage combinations, phage Sergei and Munch that are fully phage resistance 
independent, as well as Munch and Season12 that are partial phage resistance independent, along 
with Sergei Munch and Season12 alone were tested against the wild type strain according to the 
Materials and Methods. Results obtained from this experiment are shown in Figure 16. By 
testing phage Sergei, Munch and Season12 alone against the wild type Salmonella strain, 
regrowth of bacterial culture was observed starting at 7, 6 and 5 hours, respectively. Observation 
of bacterial regrowth is consistent with the rise of phage-insensitive mutants in the culture. By 






no regrowth was observed during the 12-hour experiment, demonstrating a significant 
improvement of antimicrobial efficacy against tested Salmonella strain. In contrast, by using the 
combination of two phages that are partial resistance independent (Season12 and Munch), no 
improvement of antimicrobial efficacy was observed.  
 
 
Table 5. Characterization of phage cross-resistance 
  
1. WT stands for wild type strain of S. Anatum FC1033C3.  
2. MutSergei stands for Sergei-resistant mutant of S. Anatum FC1033C3.  
3. Numbers displayed indicates EOP = number of plaques formed on each phage mutation/number of plaques formed 
on wild type S. Anatum FC1033C3.  
 
 
6. Abilities of Phages on Reducing Salmonella Population in Two Testing Models 
 Treatments with single and mixed phages were tested against S. Anatum FC1033C3 in a 
cattle hide model and a soil model. Preliminary study of soil model was performed by testing 




WT1 MutSergei2 MutSeason12 MutMunch MutSw2
Sergei 1.003 <10-7 0.98 0.75 0.70
Season12 1.00 1.10 <10-7 <10-7 1.15
Munch 1.00 0.02 0.02 <10-7 0.02








Figure 16. Efficacies of phages alone and in combination against S. Anatum FC1033C3 in a 
microtiter-plate based assay. Bacterial inoculum at ~105 CFU/mL was placed in 96-well 
microtiter plates and challenged separately with single phages or phage mixtures at concentration 
108 and 106 PFU/mL. The plates were incubated at 37 °C with double orbital shaking in a Tecan 
Spark 10 M plate reader and growth was monitored by measuring OD550nm at 30-min intervals 
for 12 h. Growth curves were achieved by plotting OD after baseline adjustment against time. 
Three biological replicates were performed in this assay. Blue, orange and gray curves represent 
growth profiles of phage treatments at 108 PFU/mL,  phage treatments at 109 PFU/mL and 




















































































































FC1033C3 and results were shown in Figure 17. Phage treatment duration greater than 24h 
didn’t exhibit difference in bacterial reduction (see Figure 17), thus, soil experiment with 1h and 
24h treatment duration were selected.  
Results showing the bacterial survival of controls and phage treatments in cattle hide and 
soil models are shown in Figure 18 and Figure 19, respectively. Results from additional sand 
model are presented in Figure 19.  
 In the hide model, except for phage Season12 in both treatment concentrations, phages 
alone or in combination in either treatment concentration were able to significantly reduce 
Salmonella populations on cattle hides compared to the positive control at 5.74 log10 CFU/cm2. A 
reduction of 1.75 log10 CFU/cm2 was obtained by using phage treatment of Sw2 alone at 109 
PFU/mL, which was the highest bacterial reduction among all treatments performed. Dosage 
effects were observed across bacterial survival of phage treatments, with statistically significant 
differences observed between two treatment concentrations in phage Sergei and Sw2.  
 In the soil model with 1 hr treatment duration, statistically significant reductions were 
observed only in treatment concentrations at 109 CFU/mL of phage Munch, Sergei and Sw2 
alone and combinations of Sergei + Sw2 and Sergei + Munch. Sergei was able to reduce 
bacterial concentration from 6.33 log10 CFU/g (control) to 4.95 CFU/g, and this 1.38 CFU/g 
reduction was the greatest reduction observed across all phage treatments. Phage Sergei alone 
and its combination with Munch showed statistically significant dosage effect (p<0.05) (Figure 
19). In the 24 hr treatment experiment, phage Sw2 and its combination with Sergei was able to 
significantly reduce the bacterial population in soil compared to the control treatment at either 







Figure 17. Bacteriophage survival after phage treatments in soil preliminary experiment. Bars in 
this figure indicate bacterial survivals of 1h, 24h and 72h phage treatments in soil preliminary 
experiment. The colors of bars indicate phage treatments with Sergei alone, Sergei and Munch 





Figure 18. Bacterial survival after phage treatments in a cattle hide model. Bars in this figure 
indicate bacterial survivals of 1h phage treatments in cattle hide model. The colors of bars 
indicate two phage treatment concentrations at 108 and 109 PFU/mL. Solid line indicates positive 
















































































A.                                                                 B.    
Figure 19. Bacterial survival after phage treatments in a soil model. Figure 19A and 19B indicate 
bacterial survivals of phage treatments in soil model with treatment duration of 1h and 24h, 
respectively. Bars in this figure indicate bacterial survivals of 1h phage treatments in a soil 
model. The colors of bars indicate two phage treatment concentrations at 108 and 109 PFU/mL. 















when applied at 109 PFU/mL. Phage treatment with Sw2 at concentration 109 PFU/mL resulted 
in the greatest reduction of log10 0.82 CFU/g.  
 Comparing with the bacterial survival results between two models, treatments with 
phages alone or in combination seemed to demonstrate better efficacies in the hide model versus 
the soil model. This phenomenon led to two hypotheses of why phages displayed poor 
antimicrobial efficacies in soil: 1) due to potential inactivation by components in soil; 2) due to 
high surface area of soil needed to be covered by treatments. To further examine these 
hypotheses, Sw2 at concentration of 109 PFU/mL was selected as a representative against the 
tested Salmonella strain in a sand model with the same experimental protocol described in soil 
model. The sand model was designed to mimic the physical property of soil while providing an 
inert condition where minimal interaction between the sand and phage occurs. Results from the 
sand model are displayed in Figure 20. Sw2 was able to significantly reduce the Salmonella 
population by 0.8 log1o CFU/g in 1 hr treatment duration and continued to suppress bacterial 
growth by 0.64 log10 CFU/g in 24 hr. The inert condition provided by sand did not demonstrate 














Figure 20. Bacterial survival after treatment with Sw2 at 109 PFU/mL in a sand model. Bars in 
this figure indicate bacterial survivals of 1hr and 24 hr phage treatments in a sand model. 





























































Discussion   
1. Morphological, Genomic and Cross-Resistant Characterizations of Phages  
Before adopting bacteriophage treatment as a means of controlling Salmonella in cattle 
feedlot environments, it is important to understand the fundamental biology of phages, including 
the dynamics of phage infection, development of phage resistance in bacterial hosts, and 
ultimately the information encoded in their genomes responsible for these phenotypes.  
 Except for Munch, genomic DNA of phages sequenced in this study showed a high level 
of similarity to well-known groups of phages. Conserved functional and structural proteins found 
in these three phages provided useful information to understand dynamics of phage infection. For 
instance, finding conserved tail fiber proteins in phage genomes is essential to preliminary 
prediction of phage receptors on bacterial surface and helpful for interpretation of results from 
the phage cross-resistance experiment.  
 Sergei is closely related to phage 9NA, the type phage of a proposed new genus of phage 
9NAlikevirus [169]. The structural related proteins of Sergei, including virion portal protein, 
major capsid proteins and major tail proteins are highly identical within this phage group, with 
less than average 10% different from one another. The tailspike protein of 9NA is homologous to  
Salmonella phage P22, implying that 9NA binds to the Salmonella O antigen, has 
endorhammosidase activity, and is capable of cleaving the polysaccharide receptor [170]. The 
tail tip protein of Sergei is 80% identical to predicted tail tip protein 9NA, suggesting a 
possibility of Sergei attaching to the O-antigen as phage receptor.  
Season12 is ~ 90% identical with Chi and a well-studied Chi-like phage iEPS5 in 






such as DNA primase, DNA polymerase and DNA helicase as well as structural proteins, such as 
portal protein head-to-tail joining protein, decorator protein, major capsid protein share high 
degree of identity to Chi. Its major tail fiber protein is > 99% identical to Chi and iEPS5, with 
only two amino acid variations. Bacteriophage Chi was first isolated in 1936 and known for its 
ability to infect flagellated Salmonella spp. [172]. Adsorption mechanism of Chi-like phages 
were later studied in a closely related phage, iEPS5 [171]. Choi et al. indicated that phage iEPS5 
were only able to infect the bacterial host when the flagellum is rotating counterclockwise, 
suggesting the physical movement of flagellum generates a power that attracted phages moving 
toward to the bottom of flagellum and attaching to the bacterial surface [171]. Compared to 
phage Chi (YP_009101117), the nearly identical major tail fiber protein with 2 amino acid 
changes found in Season12 strongly suggests the flagellum being the receptor of Season12. 
Three tandem repeats of a hypothetical protein containing 320 – 339 amino acid residues were 
identified located downstream of the tail fiber protein. Interestingly, the hypothetical protein of 
the tandem repeats in Season12 was also identified in the genomes of closely related phages such 
as iEPS5 (KC677662) (9) and SPN19 (JN871591.1), but these phages contain only one copy of 
this protein. 
Sw2 was found to share ~65% sequence identity with phage T5 at the DNA level as 
determined by Emboss Stretcher. Compared to 16 tRNA genes found in T5, 29 tRNA were 
annotated in Sw2 [81]. Like other closely related phages in the genus of T5likevirus, the genome 
of Sw2 can be divided into pre-early genes, early and late genes [81]. Proteins encoded in pre-
early genes are associated with host shutdown, including 5’-deoxyribonucleotidase, A1, and A2 






lysis, followed by late gene region consists of virion structure [81]. High similarity of tail fiber 
protein found in Sw2 indicate its potential utilization of FhuA as its receptor to bacterial host, 
like T5 [173].  
Phage Munch has an usually large genome that is >300kb with 78% of genes annotated 
with a unknown function. The term “jumbo phage” is given to phages with a genome size larger 
than 200kb [174]. Jumbo phages isolated previously generally exhibited high level of genetic 
diversity with little linkage to known clusters based on phylogenetic analysis [174]. As a jumbo 
phage, morphologically, Munch has notable large virion head. Unlike most of Salmonella 
phages, Munch is AT-rich with a GC content of 35.6%. The majority of jumbo phages (95.6%) 
were isolated against Gram-negative hosts that are GC-rich, but jumbo phages tend to display an 
AT-rich genome [174,175]. Structural proteins annotated in Munch, such as major capsid 
proteins, portal proteins and baseplate proteins, are majorly associated with structural proteins of 
phage T4. Other genes that are associated with nucleotide metabolism and replication, for 
instance, DNA and RNA polymerase, were also annotated in the genome of Munch. 
Interestingly, there is a tandem repeat region located in the last 20kb of the genome, in which 13 
repeats of a DNA condensation protein, separated by three hypothetical proteins, were identified. 
This unit repeat region were not found in any related jumbo phages such as phages 121Q 
(KM507819.1), vB_Eco_slurp01 (LT603033.1), vB_CsaM_GAP32 (JN882285.1), PBECO 4 
(KC295538.1) and vB_KleM-RaK2 (JQ513383.1). Tandem duplication was also identified in 
other jumbo phages such as 121Q and G [176]. Hua et al. suggested the possibility of jumbo 
phages expanding their genomes though tandem duplication to accommodate large virion capsid 






known phage in the NCBI database, making it difficult to predict its putative receptors on the 
bacterial host. 
Phages binding to host receptor is the initial and most essential step of infection, and 
bacterial hosts develop resistance to phage majorly via modification of phage receptors. This 
defense strategy targeting phage receptor region includes loss of receptors, production of 
extracellular matrix or masking proteins [115]. Therefore, in phage therapeutic applications, it is 
preferable to use phage cocktails not only because of the advantage of expansion of host 
coverage by multiple phages, but also the necessity of  utilizing phages attaching to independent 
receptors to prevent bacterial phage-resistance and improve infection efficacy [109].  According 
to the phage cross-resistance characterization performed in this study, Sergei, Season12 and Sw2 
demonstrated resistance independence as they were able to infect the phage-resistance mutants 
from each other. This observation could potentially serve as an evidence of our prediction of 
phage receptors obtained from bioinformation analysis. Further experiment of testing 
combinations two phages that are fully phage-resistance independent in the microtiter-plate 
based method approved the concept of using phage cocktail described by Gill et al. [109]. By 
using Sergei and Munch, capable of infecting resistant mutants of each other, regrowth of 
bacterial culture was inhibited.  
2. Factors Contribute to the Antimicrobial Efficacies of Phage in Two Models 
 Suggested by Gill et al., host range and virulence are two essential components of a 
successful phage treatment as 1) specificity of phage treatments determines the bacterial host 
range that phage treatments are able to target; 2) efficacies of phage infection determine how 






Host range and virulence were determined in a previous study using a microtiter-plate 
based assay described by Xie et al. [96] and the results of four phages used in this study were 
extracted and displayed in Figure 21 and 22 (Figure 21. Host range assays were performed using 
the agar overlay spot method; Figure 22. Host range and virulence assays were performed using 
microtiter-plate based liquid assay). Phage Munch and Sw2 demonstrated a broader host range, 
capable of infecting 11 out of 20 Salmonella strains tested across multiple serovars observed in 
the microtiter-plate based assay. On the other hand, phage Sergei was able to infect strains in 
serovar Anatum, suggesting that Sergei potentially utilizes the outer decoration region of O-
antigen that is specific to this serovar instead of the conserved region towards to inner core.  
Although four phages displayed similar efficacies of plating in the spot assay, according to the 
liquid scores obtained in this study, phage Sw2 displays greatest suppression of bacterial growth 
against tested strain used in current study, S. Anatum FC1033C3, among all phages, followed by 
Sergei with second highest liquid score. This observation suggests that phage Sw2 and Sergei are 
more virulent against the tested strain in this microtiter-plate based assay and are likely to have 
better antimicrobial efficacy against targeting strain in testing models. 
Virulence of phage, or efficacy of phages to infect and lyse bacterial host is an integrated 
result of its growth kinetics, including adsorption rate, latent period and burst size [137]. 
Theoretically, phages with high adsorption rate constants, short latent periods and large burst 
sizes would be expected to produce new virions efficiently during the infection cycle [138]. 
Others suggested that a high adsorption rate is associated with low plaque size and productivity, 
which could further lead to slower growth rate [177]. In the current study, by looking into 






when measuring virulence in the microtiter-plate assay against S. Anatum FC1033C3, which 
correlated with a model suggested by Gellet et al [177]. Gellet el al. suggested that phages with 
low adsorption rate advanced in plaque size and productivity, which allows phage to reproduce 
efficiently for bacterial elimination [177]. Lindberg et al. proposed in their model study that 
phages with high adsorption rates but longer lysis times grow slower than ones with lower 
adsorption rate but shorter lysis time, this theory did not seem to correlate with the kinetics 
parameter measured in this study [178]. Lindberg et al. also indicated in their study that the lack 
of correlation between growth kinetics and integrated growth rate is due to the fact that 
individual phage traits are poor surrogates for phage growth rate, even though the phage growth 
rate is determined as a function of individual phage traits  [178]. 
To better demonstrate the correlation between two host range assays and phage 
antimicrobial efficacies in ex vivo models, experimental results obtained in previous and current 
studies are summarized in Table 6 [97]. Sergei and Sw2 that were capable of producing a strong 
signal in the microtiter plate liquid assay were also capable of achieving a higher reduction in 
both ex-vivo models, implying that antimicrobial efficacies of phages in testing models are 
correlated with their virulence in the liquid assay. The tendency of spot assays to overestimate 
phage virulence was also observed by Henry et al., in which phage Season12 and Munch that are 
capable of efficiently making plaques does not exhibit strong bacterial suppression in either 
microtiter-plate assay and two ex-vivo models [112].  This phenomenon demonstrated a similar 
concept to the observations of Lindberg et al. [113], where phage growth rate in liquid culture 








Figure 21. Host range from agar overlay spot method. Phage host range as measured by spotting 
on soft agar overlays. Adapted from Xie et al., 2018 [96]. Phages were plated at the routine test 
dilution (RTD, determined as the first tenfold serial dilution of phage that formed countable 
plaques lawns of its own host) and 100 X the RTD. Phage were tested against a panel of twenty 
Salmonella strains and scored on the following criteria: phage forming > 50% of the number of 
plaques formed on its host strain at its RTD = 4; phage forming 5% to 50% of the number of 
plaques formed on its host strain at its RTD = 3; phage forming a zone of confluent lysis but no 
individual plaques at 100 × RTD = 2; phage forming individual plaques at 100 × RTD = 1; no 
plaque or clearing formation at either dilution = 0. The scores from three replicate experiments 
















































































































































































Sergei 4 4 4 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Season12 0 4 0 0 0 2 0 2.7 0 0 0 0 0 4 4 0 2 0 4 0
Munch 4 4 4 3.3 0.3 0 4 4 4 3.7 4 4 1.7 2 4 2 2 0 0 0







Figure 22. Host range from microtiter plate liquid assay. Adapted from Xie et al., 2018 [96]. 
Values indicate average liquid assay scores are described by Xie et al. To aid the reader, cells are 
shaded with stronger color intensity indicating a greater score. Assay score represents the 
differences in area under the bacterial growth curve with and without phage. Since the largest 
standard deviation observed in any individual assay was 10.89, an assay score of greater than 
10.9 was used as a cutoff to distinguish a legitimate signal from noise. Larger numbers indicate a 
greater suppression of bacterial growth in the presence of phage. Boxed cells indicate the initial 









108 65 55 57 63 0 2 6 0 0 0 0 0 0 0 0 0 0 1 0 0
106 58 51 52 56 0 2 4 0 0 0 0 0 0 0 0 0 0 0 0 0
108 13 10 0 0 25 80 1 49 7 13 11 4 1 79 79 2 12 12 25 3
106 2 32 0 0 3 46 0 34 0 0 1 0 1 76 79 0 8 2 21 0
108 9 27 9 9 19 0 17 60 27 29 0 48 45 56 17 7 31 0 0 0
106 6 0 8 7 0 0 21 45 7 0 0 47 39 23 17 9 47 0 0 0
108 77 86 77 78 0 2 21 21 0 13 27 0 4 0 0 21 8 35 19 0











































































































































































































In addition to their virulence predicted in liquid culture, bioinformatic analysis could also 
provide additional information explaining phage efficacies in ex-vivo models. High level of  
homology in the tail region of Season12 suggested that it likely attaches bacterial flagellum as its 
reception during the infection [89,179,180]. Conditions involved with the ex-vivo models 
performed in this study are sub-optimal to bacterial growth and survival, including nutrient 
starvation, desiccation and pH shift, resulting in potential stress response of Salmonella [181]. 
Downregulation of genes responsible of protein synthesis was often observed during the stress 
response in Salmonella, including several genes involved in flagellar biosynthesis (e.g flgA, flgB, 
flgH, flgBA), resulting in decreased motility of bacteria cells [182]. The fact that Chilikevirus 
were only capable of infecting motile Salmonella cells explained its poor antimicrobial efficacies 
in ex-vivo models due to potential non-motile stage of Salmonella in stressed condition.  
 A reduced antimicrobial efficiency of phage treatments was observed in the soil model 
compared to the hide model, suggesting that either phages were inactivated by chemical 
compounds or physical structure in soil, or phage treatment was incapable of covering a high 
amount of surface in fine particles like soil. The additional inert model by using sand provided 
important information that explained the reduced phage efficacies in soil model. First, bacterial 
growth between 1and 24 hr treatments in the soil and sand model are 2.63 log10 CFU/g and 0.78 
log10 CFU/g, suggesting that the lack of nutrition supporting bacterial growth in the sand model 
resulted in only a minor increase of bacterial population compared to the soil model. In addition, 
using an inert sand model for efficacy testing of phage did not result in a greater reduction of 
bacteria load, implying that the reduced phage efficacies observed in the soil model is unlikely 






Table 6. Comparison of two host range method in predicting phage efficacies in two models 
 
* Star symbols indicate that the bacterial reductions are significantly compared to controls 
 
 
that the increased resources in soil available for bacterial growth led to an increase of bacterial 
resistance to phages [183]. In our current study, by using a sand model with reduced nutrient 
resources, phage efficacy did not improve with reduced bacterial growth, indicating that phage-
resistance developed during the 24 hr treatment may not contribute to the reduced efficiency in 
phage treatment. This phenomenon may also explain why treatments with phage combinations 
did not exhibit a synergy effect compared to single phage treatments. Sergei and Sw2, which 
displayed stronger bacterial inhibition in the cattle hide model, also achieve greater reduction in 
the soil model with 2 treatment durations, implying that treatment efficacies achieved in testing 
models are phage-dependent instead of subject-dependent. In our current model, bacterial 
reduction achieved by phage treatments seemed to be relevant to virulence of phage itself and the 
Experiments
Phages











1 h 24 h
Sergei 4 55 1.60* 1.38* 0.45*
Season12 4 10 0.50 0.22 0.33
Munch 4 27 0.83* 0.53* 0.33






availability of physical contact between the treatment object and phages, with little association 









Asymptomatic Salmonella carriage in beef cattle is a food safety concern and the beef 
feedlot environment and cattle hide are reservoirs of this pathogen. Previous studies on 
mechanisms of Salmonella transmission and colonization of lymph nodes suggested that entry 
route of Salmonella could be through oral uptake via contaminated food and drinking water, or 
transdermal transmission via skin abrasion and insect bites. Previous study identified the feedlot 
environment as reservoirs of bacteriophages that may prove useful as a means of controlling 
Salmonella in the beef cattle feedlot environment and cattle hide. In recent decades, attention for 
new antimicrobials to control bacterial pathogens and treat infectious diseases were increased 
with growing threat of antibiotic resistance. Bacteriophages have re-emerged as an attractive 
alternative to combat antibiotic resistant bacteria. The capacity of bacteriophages to efficiently 
infect and lyse the target bacterial strain is essential for successful phage therapy [109-111]. 
Prediction models used to determine treatment efficacies of phages in vitro yield various 
accuracies depending on methods used.  
In the current study, a liquid culture-based assay was developed in a 96-well microtiter 
plate format to measure the phage host range and virulence for a collection of 15 Salmonella 
phages against a panel of 20 Salmonella strains representing 11 serovars. The majority of the 
host range results from two methods were in agreement including in cases where a bacterial 
strain was insensitive to the phage. Each method produced a false-negative result in 19/300 (6%) 






tended to indicate greater phage sensitivity than the microtiter assay even though direct 
comparisons of the response magnitude between the two methods is difficult since they operate 
on different mechanisms.  
In the two ex-vivo models used to determine antimicrobial efficacy of phage treatments, 
phage Sergei and Sw2, which displayed greater virulence in the microtiter plate based assay, 
were able to achieve greater bacterial reduction of Salmonella. The ability of phages on 
suppressing bacterial growth in ex-vivo models showed high degree of correlation with their 
virulence measured by the liquid assay but little association with the spot assay, suggesting that 
spot assay tends to overestimate antimicrobial efficiency of phages. This tendency was also 
observed by Henry et al. [112] in which phage PhiKZ displaying a EOP of 1.2 performed poorly 
in liquid culture and in an in vivo model of phage therapy, which suggests that measures of 
phage virulence may be more useful than measures of plating efficiency when selecting phages 
for use in antibacterial applications. The antimicrobial efficacies of phage treatments are also 
found to be phage-specific but not model-dependent, implying that a phage capable of achieving 
great bacterial reduction in one model is likely to perform well in another.  
The current study also explored reasons behind the reduced treatment efficacies of phage 
in soil model by using a sand model. Result obtained in this study suggested a potential common 
difficulty of antimicrobial treatments in fine particle model due to the high surface area needed 
to be covered by treatments. In addition, treatments with phage combinations did not display an 
increased bacterial reduction in both models, suggesting that bacterial resistance to phage may 






To better validate the microtiter-plate based liquid assay in predicting antimicrobial 
efficacies of phages, future studies can be expanded to other bacterial-phage combinations as 
well as other ex-vivo or in-vivo models. Phages demonstrating ability of significant bacterial 
reduction could be used in challenge studies in in-vivo cattle hide models and in feedlot 
environment to explore practical application of phages as an intervention to prevent Salmonella 
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